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ABSTRACT 
 
Background: The use of mobile devices and medical software applications (apps) for 
mobile devices have been increasing amongst medical professionals. Medical apps can be 
used for a variety of functions and clinical decisions may be made based on the 
information provided by these apps. However these apps do not need to have a medical 
professional involved in the development before being made available for use. Little data 
could be found regarding app use amongst anaesthetists. 
Objectives: To describe anaesthetists in the Department of Anaesthesiology at the 
University of the Witwatersrand’s use of medically related mobile device applications and 
the assessment of the credibility of those most commonly used. 
Methods: Anonymous and self-administered questionnaires, requesting demographic 
data and information regarding apps used, were distributed among anaesthetists. From 
the participants list of apps the five most commonly used were assessed against a 
credibility template.  
Results: A total of 127 questionnaires (61% of the department) were distributed with 117 
(92.1%) being returned. All participants owned a mobile device, the most popular brand 
being Apple. There were 99 (84.6%) participants who have used a medical app in their 
practice. Differences in app use were seen between different age groups, 88.0% in those 
less than 40 years vs 58.8% in those 40 years or older. More females than males (35.1% vs 
22.0%) and more participants younger than 40 years (31.8% vs 10.0%) used an app daily. 
Daily use of apps varied from 0% to 33.3% among participants with different years of 
experience. The most commonly used apps were Medscape (61.6%), ECG Guide (10.1%), 
Qx Calculate (10.1%), The Oxford Handbook of Anaesthesiology (9.1%) and Pedistat 
(9.1%). Recommendation by a colleague influenced the choice of app in 40.9% of 
participants. The five most commonly used apps in the department all appeared credible. 
Conclusions: Mobile devices were owned by all participants and 84.6% made use of 
medical apps in their practice. The majority of participants used an app at least once a 
week with the older participants making less use of them. Medscape was the most 
frequently used app. The five most commonly used apps in the department all appear 
credible.  
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Section 1: Literature review 
 
1.1. Background 
The availability and use of mobile devices and their related software applications (apps) 
have been increasing over the last few years, and with that has come the development of 
medically related apps. These apps have been developed for use by either a patient, a 
clinician or both. The development of an app requires knowledge of software 
development. However, in terms of medically related apps, the software developer may 
not necessarily have a clinical background, be working with a medical professional or be 
affiliated with an institution involved in the medical field. 
 
Previously, medical professionals had to rely on textbooks, journal articles, reference 
charts and tables, calculators etc. for medical information. These medical professionals 
often used what was known as the “Little Black Book” to record information for future 
reference.  
 
In this review of the literature, mobile device apps will be discussed under the following 
headings. Mobile device ownership amongst medical professionals, app use among 
medical professionals, medical professional involvement (MPI), regulation by medical 
controlling bodies and reviews of apps. This review then ends with independent 
validation of apps and the difficulties involved in fully assessing apps used by medical 
professionals. 
 
1.2. Mobile device ownership by medical professionals 
Within the medical community, mobile device use is popular and appears to be on the 
increase, although differences may exist between levels of training (medical student to 
consultant) and even amongst various specialties. With regard to smartphone ownership 
between different levels of training, a 2012 study in the United Kingdom among medical 
students and “junior doctors,” that is interns, was conducted via an online survey. There 
were 257 medical students from 1706 surveys who responded and 79% of those owned 
some form of smartphone. Amongst the junior doctors, 131 replies from 601 surveys 
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were received with 74.8% of those responding owning a smartphone. In both groups, 
Apple was the more popular phone brand where 56.6% of students and 68.4% of junior 
doctors owned an Apple iPhone respectively. (1)  
 
Between 2013 and 2014, smartphone ownership amongst junior doctors appeared to 
have increased. A written voluntary questionnaire was given to 82 interns based at two 
hospitals in Ireland during 2013 (Mater Misericordiae University Hospital, and St Vincent’s 
University Hospital). Of the 61 respondents, 98.4% of interns owned some form of 
smartphone and the Apple brand was owned by 76.7% of those. (2)  
 
In 2014, a survey conducted in Ireland by the National University of Ireland in Galway sent 
203 interns in two of its teaching hospitals an online survey, with 108 being returned. 
Responses showed that 94.4% of interns reported owning a smartphone. The Apple 
iPhone was again the more popular brand, with 66.7% of interns owning one. (3) 
 
In 2014, the University of Alberta in Canada also described smartphone ownership. 
Initially a group of 18 medical students, residents and faculty members were interviewed. 
This was followed by an online survey where 2550 surveys were sent out with a low 
response rate of 213 surveys. Overall, smartphone ownership was 87%, with 90% of 
residents and 85% of both medical students and faculty members owning some form of 
smartphone, the Apple iPhone once again being the most popular brand. (4) 
 
A study done at the University of California in 2011 to compare smartphone usage 
amongst 27 specialties, sent an online survey to residents and attending doctors at 678 
Accreditation Council for Graduate Medical Education institutions in the United States. 
Respondents included 1397 residents, 524 fellows and 1385 attending physicians 
(n = 3 306). On average, 85% of medical professionals owned some form of smartphone. 
Between the different specialties, smartphone ownership varied from 77.3% amongst 
radiologists to 98.1% amongst surgical subspecialties. The Department of Anaesthesiology 
was not specifically mentioned and possibly placed under the category of “other” in the 
study. The most popular smartphone brand was the Apple iPhone with 48% of 
respondents owning one. (5)  
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A separate study specifically on urology trainees at the University of Limerick, Ireland in 
2014 showed that 100% of its members (36 respondents out of 44) own a smartphone 
(6). 
 
1.3. App use by medical professionals 
Apps are programs designed for use on a mobile smartphone or tablet, the scope of 
which has extended into various fields, including medical disciplines. 
 
1.3.1. Categorising app use in the medical field 
Mobile device apps can be developed for an array of potential uses. The following five 
categories by have been created by Ventola (7) a consultant medical writer. 
 Administration: apps can be used for time management, such as the calendar feature 
built into the smartphones, or can be used for information storage, such as on “the 
cloud”. Information sharing can also occur via these apps. Note taking, highlighting of 
documents and storage of photographs fall under this category. Many of these apps 
are not designed specifically for the medical field. 
 Health record and maintenance: apps are designed to record a patient’s data into a 
patient’s medical record or into a hospital system. They can be used to facilitate 
patient handover or allow access to patient records, such as laboratory data, x-rays, 
ECG’s and the like, however remote. 
 Communication: apps in this category are used in order to improve communication 
between healthcare workers. Again, the majority of these apps are not specifically 
designed for the medical profession. Examples of apps used for communication 
include WhatsApp and Skype. 
 Reference and information gathering: apps designed to allow for the searching of 
medical literature; including journals, drug references and medical news. 
 Medical education and patient management: These are apps that may assist in clinical 
decision making, such as the use of medical calculators (defined later) and screening 
tools, or those apps that assist in patient monitoring. Patient monitoring can occur by 
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connection of the app to the monitors in a ward or they may be used with a patient at 
home to measure blood pressure or glucose for example. (7)  
 
1.3.2. Use of apps by medical professionals 
Medically related app use appears to be increasing. Amongst UK interns in a 2012 study, 
of those owning a smartphone (98 interns), 75.5% reported having at least one medical 
app that they could potentially use in their clinical practice. However, 29.6% reported that 
they used an app at least once a day while 27.6% reported never using their apps. The use 
of an app one or more times a week accounted for 26.5% of junior doctors (1). No 
mention was made as to whether the apps downloaded were free or purchased.  
 
In 2013, 91.7% of 60 interns owning a smartphone at the Mater Misercordiae University 
Hospital and St Vincent’s University Hospital had at least one medically related app on 
their phones. Of those owning apps, 43.6% reported a minimum daily use of one or more 
apps. Other categories of app use frequency were not considered here. The Oxford 
Handbook of Clinical Medicine was the most commonly used app. (2)  
 
In 2014 at the National University of Ireland, 102 of 108 interns responding owned a 
smartphone. There, 50% of interns used an app daily, while 14.7% said they used an app 
at least once a week. The most popular app used was the British National Formulary. (3)  
 
The above studies show that preferred apps differ between different institutions.  
 
With regard to the apps used, popularity may depend on the level of training of the 
individual medical practitioner and which specialty they are in. A study on urology 
trainees found that 77.8% downloaded some form of medically related app, lower than 
that used by interns in other studies (1, 2) with 25% using an app at least once daily. The 
most commonly used apps by these urologists was E-Logbook, (75% had downloaded it 
on their mobile devices), followed by the Oxford Handbook of Urology, bought by 46.4% 
of urologist trainees. (6) 
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Another factor that may potentially play a role includes the cost of the app. Prices of apps 
mentioned in these studies vary extensively, from free apps to apps costing around €90 
(2, 6). Among interns in Ireland 91.7% owned at least one app of which 52.3% were paid 
for apps (2). Urology trainees in Ireland had fewer registrars purchasing an app, 30.6%, 
despite 77.8% downloading at least one (6). This suggests that cost may be a factor 
influencing the choice of apps downloaded.  
 
1.4. Medical professional involvement in the development of apps 
As the use of medically related apps increases, concerns exist as to whether the apps 
currently available come from trustworthy sources for use in clinical practice (4). Studies 
have been done by various disciplines looking at apps with a particular function and have 
shown poor levels of MPI, which is taken to include a named clinician, affiliated institution 
or from a manufacturer of medical equipment. 
 
1.4.1. Surgical apps reviewed 
Colorectal apps were reviewed by O’Neil and Brady (8) at the University of Edinburgh. 
Sixty-three apps were identified and reviewed with only 32% reporting MPI in the form of 
a named clinician or organisation. Twenty-nine apps were designed for patient education, 
with only four of them having MPI. Eight apps were directed towards education of health 
care workers and only one did not have any form of MPI. Six apps were developed as a 
“diary” to record follow up dates, bowel habits and other medical problems. Two of these 
apps mentioned involvement of a medical professional, but only one included a named 
medical professional. Cancer support was offered by four apps, only two of which had 
MPI. Five reference apps out of 11 had some medical professional involved in 
development. The remaining five apps were classified as “miscellaneous” and only one of 
those had some MPI. In this study, 65% of the apps without documented MPI charged for 
the use of the app.  
 
Vascular themed apps were also reviewed by O’Neil, Brady and Carter (9), of which 49 
were found and reviewed. Only 29% reported MPI, although one did not clarify in what 
form, whether a named clinician or organisation. Eleven of these were directed towards 
patient education on various vascular conditions with only one having MPI. Twelve apps 
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were aimed as education tools for health care workers, yet only 75% of these had any 
form of MPI. There were four surgical textbooks which contained vascular content, all 
four of which had documented MPI. Three apps were patient diaries, three diagnostic 
aids for patients, two apps analysed vascular ulcers and the remainder were classed as 
“miscellaneous”. None of the apps in these categories had named medical professionals 
involved in development. Of the apps reviewed, 67% were charged for.   
 
A study at the University of California, focused on neurosurgery apps and found 111 
related to neurosurgery. There were 66% of these which were found to have MPI in their 
development. Apps were divided into seven categories; 16 clinical tools, 17 conference 
adjunct, 27 education (for health care workers), 18 literature, 15 marketing, 10 patient 
information and 8 reference. Only 16 of the apps designed for health care worker 
education showed evidence of MPI. With regard to the apps classified as clinical tools, the 
functions of which also include “clinical decision support, prognosis scores, risk 
calculators”, 10 had MPI. The apps aimed at patient education had only one showing MPI. 
Of these apps, 36% of these apps had to be paid for, although how many of the paid apps 
had some MPI is not mentioned. (10) 
 
Breast related apps were reviewed by the Department of Surgery at the Imperial College 
in London and included 185 apps for review. They were classed into 15 categories; 94 
educational tools, 30 self-assessment apps, 3 breast cancer risk assessment tools, 30 for 
raising breast cancer awareness and 8 for social networking and support. Two apps 
claimed to be able to remotely heal breast cancer. The remaining categories included 
visualisation tools, conference guides, glossaries, patient diaries, breast services listing, 
product advertisement and “breast enhancers”. Apps that were for conferences, 
advertisements, fund-raising and social networking were then excluded as they did not 
require any evidence based practice. As such, 148 were included. Only 14.2% 
documented that their app was evidence based with a further 12.8% mentioning a 
medical professional being involved, of which 78.9% of these specifically named the 
medical professional. Only 20% of the apps used as a self-assessment tool had MPI or 
evidence based information. This study mentions that 29 apps “had the potential to cause 
indirect harm” to a patient. Twenty-six of these 29 apps had no form of MPI. (11) 
7 
 
 
Cardiothoracic apps were reviewed by the Department of Cardiothoracic Surgery at King’s 
College Hospital. Their search included 379 apps, 21% of which were affiliated with a 
named medical professional or institution. (12) It is mentioned that there are apps 
specifically for patient education while others are intended for healthcare workers. 
However, how many were directed towards one or the other is not mentioned.  
 
1.4.2. Apps reviewed by other disciplines 
The Pharmacy Department at the Complejo Hospialario in Spain reviewed 23 apps on viral 
hepatitis for MPI. Four were for patient education, 12 for health care workers and seven 
were meant to be used by both. MPI was found in only 56.5% of the apps. It was not 
reported how many of these apps had to be purchased, but it was mentioned the cost of 
purchasing apps ranged from €0.69 to €89.99. (13) 
 
From an anaesthetic point of view, apps used for the conversion of opioids into 
equivalent doses were reviewed by Haffey, Brady and Maxwell (14). Here, 23 opioid 
conversion apps were included in the study. Only 22% documented MPI from an 
anaesthetist, palliative care doctor or another physician in their development. However in 
one app, where a medical professional was involved, it was developed by an individual 
termed a “training grade doctor”. Further to this only 43% provided some reference. 
Eighteen of these apps had to be paid for, with prices ranging from £0.69 to £6.67. 
 
Ophthalmology apps have been reviewed in Melbourne by Cheng, Chakrabarti & Kam 
(15). A search for potential apps was only conducted on the Apple iStore and revealed 
182 for inclusion into the study. Apps were classified into one or more of seven 
categories; 37 for vision testing, 36 education for eye care professionals, 36 for patient 
education, 35 as clinical calculators and scoring systems, 26 for education of non-eye care 
specialists and 5 as ophthalmic atlases. Overall, 37% of these apps had MPI. Apps 
designed for ophthalmologists had 51.6% MPI, those for optometrists had 44.3% MPI, 
non-eye care specialist apps had 31.1% MPI and apps designed for the general public had 
20.6% MPI in the development of the programmes.  
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In a review in 2012 of microbiology themed apps Visvanathan, Hamilton & Brady (16) 
found 94 relevant programs amongst the various app stores and they categorised them as 
“reference”, “educational”, “antibiotic” and “other”. Only 34% of these apps had reported 
MPI, which included “microbiologists, pharmacists and specialist nurses”. It is not 
mentioned whether these medical professionals were named in the app. A further 20% 
cited “subject matter experts, team of doctors or hospital team” as their source. These 
apps were regarded as having MPI. No authorship at all was mentioned by 39.4% of apps, 
which included four antibiotic dosing calculators, while the remainder stated no MPI. 
Despite this, 78% of the reference apps, which includes those with and without MPI, 
charged for the use of the app with prices ranging from £0.64 to £99.50. 
 
These studies reflect a paucity of MPI in the development of the available medically 
related apps in a wide range of disciplines, and also that many of those which are not 
validated may actually charge for the use of the program.  
 
1.5. Regulation of apps 
With regards to the regulation of apps, certain regulatory bodies, such as the Food and 
Drug Administration (FDA) are starting to become involved. The FDA currently has 
comprehensive guidelines concerning the regulation of medically related apps which were 
released in February 2015.  
 
The following are definitions made by the FDA regarding mobile devices: 
 “Mobile platform: defined as commercial off-the-shelf computing platforms, with or 
without wireless connectivity that are handheld in nature. Examples of these mobile 
platforms include mobile computers such as smart phones, tablet computers, or other 
portable computers  
 Mobile Application (Mobile App): is defined as a software application that can be 
executed (run) on a mobile platform, or a web-based software application that is 
tailored to a mobile platform but is executed on a server  
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 Mobile Medical Application (Mobile Medical App): is a mobile app that meets the 
definition of device in section 201(h) of the Federal Food, Drug and Cosmetic Act 
(FD&C Act)  
o Section 201(h) defines a device as ‘… an instrument, apparatus, implement, 
machine, contrivance, implant, in vitro reagent, or other similar or related 
article, including any component, part or accessory’, that is ‘… intended for use 
in the diagnosis of disease or other conditions, or in the cure, mitigation, 
treatment, or prevention of disease in man…’ or ‘… intended to affect the 
structure or any function of the body in man or other animals…’ Thus, software 
applications that run on a desktop computer, laptop computer, remotely on a 
website or ‘cloud,’ or on a handheld computer may be subject to device 
regulation if they are intended for the use in the diagnosis or the cure, 
mitigation, treatment, or prevention of disease, or to affect the structure or 
function of the body of man. The level of regulatory control necessary to 
assure safety and effectiveness varies based upon the risk the device presents 
to public health.  
 Regulated Medical Device: is defined as a product that meets the definition of device 
in section 201(h) of the FD&C Act and that has been cleared or approved by the FDA 
review of a premarket submission or otherwise classified by the FDA  
 Mobile Medical App Manufacturer: is any person or entity that manufactures mobile 
medical app in accordance with the definitions of manufacturer in 21 CFR Parts 803, 
806, 807, and 820” (17) 
 
According to the definitions that have been set out, the FDA have divided medically 
related apps into three categories: 
 those that are not considered a medical device 
 in which the FDA “intend to exercise enforcement discretion” 
 those that are to be regulated by the FDA. (17) 
 
Those apps which are considered a medical device for which the FDA “intends to exercise 
enforcement discretion (meaning the FDA does not intend to enforce requirements under 
the FD&C Act)” (17) are included in the definitions below: 
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 “Mobile apps that provide or facilitate supplemental clinical care, by coaching or 
prompting, to help patients manage their health in their daily environment 
 Mobile apps that provide patients with simple tools to organise and track their health 
 Mobile apps that provide easy access to information related to patients’ health 
conditions or treatments (beyond providing an electronic “copy” of a medical 
reference) 
 Mobile apps that are specifically marketed to help patients document, show, or 
communicate to providers potential medical conditions 
 Mobile apps that perform simple calculations routinely used in clinical practice 
 Mobile apps that enable individuals to interact with PHR systems or HER systems” (17)  
 
The apps under full FDA control are further classified as: 
 “Mobile Apps that are an extension of one or more medical devices by connecting 
such device(s) for purposes of controlling the device(s) or displaying, storing, 
analysing, or transmitting patient-specific medical device data 
 Mobile apps that transform the mobile platform into a regulated medical device by 
using attachments, display screens, sensors or by including functionalities similar to 
those of currently regulated medical devices. Mobile apps that use attachments, 
display screens, sensors, or other such similar components to transform a mobile 
platform into a regulated medical device are required to comply with the device 
classification associated with the transformed platform 
 Mobile apps that become a regulated medical device (software) by performing 
patient-specific analysis and providing patient-specific diagnosis, or treatment 
recommendations. These types of mobile medical apps are similar to or perform the 
same function as those types of software devices that have been previously cleared or 
approved”. (17) 
 
Other regulating bodies involved in the control of medical devices include the European 
Commission, which also encompasses the United Kingdom. No specific guidelines on 
medical apps have been formalised and apps currently fall under the heading of “Stand 
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Alone Software”. Similar guidelines to those developed by the FDA are enforced for this 
stand-alone software. (18)  
 
The South African Medicines Control Council will regulate software depending on how it is 
intended for use by the manufacturer. There is no specific definition for apps included 
currently in the guidelines and therefore apps are treated as software. Software is 
defined as that which “operates as a controlling agent for an electronic device”. 
Regulation is classified according to the following definitions: 
 “Software that is part of a device and is supplied with a medical device 
o It will be regulated as part of the device 
 Software or an accessory to a device that is a device in its own right if it is supplied 
separately from the related device 
o It will be regulated as a separate medical device 
 Software that is used as a diagnostic or therapeutic tool  
o Will also be regulated as a separate medical device 
 Upgrades to software supplied separately 
o Regulated as a separate medical device 
 Corrections to software errors that have been supplied with a device. Please note: 
Must be a replacement part with no additional functionality 
o Not considered a medical device 
 Software that is used in combination with other equipment for handling general 
patient related information 
o Not considered a medical device” (19) 
 
1.6. App reviews 
Despite the regulations that have now been developed surrounding apps, concerns still 
exist as to whether these definitions are “ambiguous and open to interpretation”. (20) As 
such, certain websites have been developed in an attempt to offer guidance with regard 
to the available apps. One such site, iMedicalApps.com, has been cited as a trusted Web 
2.0 source by the Cochrane Collaboration (21). The site offers reviews of medical apps as 
well as news releases regarding medical devices. They are however, not a regulating body 
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and do not control which apps may be released by the various app stores. They only offer 
advice and reviews of the apps available for download. Another site, Happtique.com was 
initially developed as a site giving certification to medically related apps, allowing 
individuals the ability to review the trustworthiness of the app they wish to acquire (22). 
However, they have halted this service as two apps previously determined as safe had 
issues surrounding privacy and security (23). At the time of this literature review, they 
have not resumed certification.  
 
There have been other attempts to improve the credibility of apps. Apple iStore have 
started removing apps, particularly those acting as drug reference sources, in line with a 
new policy stating that medically related apps need to have their sources cited (24). At 
the time at which this literature review was done, no similar policy could be found for the 
other commonly used app stores. This may change in future, especially if greater 
clarification occurs surrounding which apps would require regulation 
 
1.7. Independent validation 
Due to difficulties surrounding the regulation and validation of apps, independent studies 
have been performed to validate the use of specific apps. The studies are grouped 
according to similar app functions: 
  apps used for medical calculations 
 apps used as a screening tool 
 apps acting as a replacement for currently available tools 
 apps that allow the smartphone to act as an “accessory” for a current device 
 
1.7.1. Apps used for medical calculations 
A medical calculator is a form of software where an algorithm or scoring system has been 
programmed to facilitate ease of calculation. Scoring systems would require specific 
criteria for the score to be given. The apps that have been developed which include 
medical calculations in their programming may contain a wide range of formulae and 
scoring systems that encompasses many disciplines or they may contain one or a few 
algorithms or scores that would be dedicated to a particular function or discipline. 
13 
 
 
A study by Payne and Wharred (25) in 2014 reviewed apps that had three or more 
calculator functions, of which 14 apps were eventually included. All the calculations were 
then listed and five internists were asked which calculations they would prefer. If four of 
the five internists selected a specific calculation, then it was included in the study. Of the 
476 available calculations, 13 were eventually tested. Ten different values for each 
calculation were used. Only 85% of the calculations chosen were 100% accurate amongst 
all 13 apps. Only the Child-Pugh score and the Model for End-Stage Liver Disease score 
had a lower accuracy of 97% and 95% respectively. There was however no change in the 
overall class with regards to the Child-Pugh score found in this study. The Model for End-
Stage Liver Disease score errors gave a higher mortality rating. However, only a small 
number of calculations available were used which included those that were thought 
necessary by internists and not those that may be useful in other disciplines. 
 
Morris et al (26) looked specifically at fluid resuscitation and replacement in burns 
patients using the Parkland Formula. Two apps were chosen and compared to the values 
obtained using a simple calculator. Nine randomly generated scenarios were created and 
34 participants calculated fluid requirements for each scenario using both of the apps as 
well as the calculator. Accuracy, speed and preference were all compared. With regards 
to speed, a significant difference was found between the different methods (p = 0.006) 
with the calculator being significantly slower (p = 0.013 and p = 0.017 respectively). With 
regard to accuracy between the different methods, the calculator was found to have a 
lower accuracy compared to either app, but this was not found to be statistically different 
(p = 0.065). Overall, participants appeared to prefer the use of a simple calculator 
compared to the apps but this preference was also not found to be significantly different. 
 
A study by Flannigan and McAloon (27) used a paediatric ICU calculator (“PICU 
Calculator”) app to calculate infusion rates for two hypothetical scenarios, one involving 
adrenaline and the other dopamine. There were 28 doctors, ranging from senior house 
officers to consultants and seven medical students who participated in the study. A 
random number generator divided the participants into two groups, one group using the 
British National Formulary for Children for the first scenario and the PICU Calculator for 
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the second scenario while the second group did the opposite. For each calculation, 
participants were given ten minutes. The infusions calculated were then divided into four 
groups; “(i) correct; (ii) correct for dose and rate but overall volume too big for 
administration in a syringe pump; (iii) incorrect; (iv) unable to complete”. Values accepted 
as being correct for dopamine was, if calculated between 5 to 20μg/kg/min and for 
adrenaline if the calculated infusion was between 0.1 to 1.5μg/kg/min. Of the 35 
participants, (28.6%) were able to achieve a correct value for the infusions when using the 
British National Formulary for Children, which included one of six senior house officers, 
three of seven registrars, one of three associate specialists and five of eight consultants. 
None of the students or foundation level two doctors (of which there were four) were 
able to calculate a correct infusion rate and volume using the British National Formulary 
for Children. When using the PICU Calculator, 100% of participants calculated the correct 
infusion dose and rate as well as volume, a difference found to be significant (p < 0.001). 
Use of the PICU Calculator was also achieved faster than the use of the British National 
Formulary for Children, with a mean time saved of 317 seconds (p < 0.01).  
 
1.7.2. Apps used as screening tools 
Apps that have been designed for disease/condition screening are mostly directed 
towards patient use.  
 
The Department of Dermatology at the University of Pittsburgh reviewed apps used in 
determining whether a skin lesion was potentially malignant or not. A total of four apps 
were found that had the ability to upload a photograph of a lesion for analysis. Three of 
these apps utilised an algorithm to evaluate the lesions in the images. It is not mentioned 
if a medical professional was involved in the development of these apps. The fourth app 
uploaded the image to a “board-certified dermatologist”, although it is not known if the 
image is sent to a single or many dermatologists. In order to evaluate the apps, images 
from the university’s database where confirmed histological diagnosis had been made 
were uploaded. A total of 188 images were used, 128 of which were benign and 60 were 
melanomas. Sensitivity and specificity of each app were tested. Sensitivity in one 
algorithm based app was 6.8%, however specificity was 93.7%. A sensitivity of 70% and 
specificity of 39.35% in the second algorithm app occurred in the second and a sensitivity 
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of 69% with specificity of 37% in the third. Sensitivity was highest in the fourth app where 
an image was uploaded to a dermatologist (98.1%) but specificity was lowest (30.4%). 
Only 18 of the 60 melanomas algorithm based apps, were identified by the app with the 
highest detection rate. It is mentioned that although these apps have attached 
“disclaimers” stating that they are for educational purposes, the authors are concerned 
that “they have the potential to harm users who may believe mistakenly that the 
evaluation given by such an application is a substitute for medical advice”. (28)  
 
BinDhim et al (29) at the University of Sydney developed an app that used the Patient 
Health Questionnaire (PHQ-9), a depression screen. If a patient’s score was high, they 
were advised to see a health care professional for further evaluation. A random 
identification number was generated for each user and data collected was synchronised 
to the research database only when a completed form was submitted. Users over the age 
of 18 were included in the study. Over a period of four months, 8241 people in 66 
countries had downloaded the app, with 6089 completing the questionnaire. Results 
show that of those without a prior diagnosis of depression, 82.5% were at a high risk for 
depression. This study shows that apps can also have the potential to be useful screening 
systems. 
 
The Stroop Test, a neuropsychiatric test for cognitive impairment, has been utilised as a 
screening test for minimal hepatic encephalopathy and has now been developed into an 
app. The validation of this app has been tested by Bajaj et al (30) in Virginia. Patients 
included had cirrhosis and were excluded if they were on psychoactive medication, 
abused alcohol or other drugs, confirmed overt hepatic encephalopathy or were red-
green colour blind. They were compared with healthy controls. Both groups underwent 
three known cognitive tests to diagnose if minimal hepatic encephalopathy was present. 
There were 125 patients with cirrhosis (of which 43 had a prior diagnosis of overt hepatic 
encephalopathy) and 51 healthy controls recruited into the study. An iPod Touch was 
used as the mobile device platform to administer the test. Within the two groups, 27% of 
controls were previously familiar with the use of an iPod touch and 24% of cirrhotic 
patients were familiar with the iPod. The app has what is termed “Stroop Off” where it 
displays a colour to be named, and “Stroop On” where the name of a colour is given but 
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the word is written in a different colour. During “Stroop On”, participants are required to 
name the colour and not the word. Reaction times are then measured. There was no 
significant difference between those who had prior experience with an iPod and those 
who did not. In the cirrhotic group, a significant correlation was seen between the MELD 
score and both Stroop Off (0.57, p<0.001) and Stroop On (0.61, p<0.001).  
 
Another screening app developed in 2014 is that of “Painometer”, which contains four 
well known pain intensity scales. This was a usability study to describe the potential 
benefit of an electronic pain diary. Both health care professionals and patients were 
included and conducted in two phases. Phase one included a convenience sample of 19 
healthcare professionals and 14 patients. Healthcare professionals were asked to use the 
scales on the app as they would for a patient, whilst patients were asked to record their 
pain intensity, a task done for each pain scale. Participants were then given an open 
ended questionnaire on the usability of the app and if any improvements could be made. 
Healthcare professionals preferred the app compared to the traditional methods for the 
scales (95% preferred the app). Some patients found the apps navigation a little difficult 
to use but otherwise had no problems. In phase two, a second usability trial was 
conducted, after changes to the app were made, based on suggestions made in phase 
one. In this trial, 15 healthcare professionals and 16 patients were included. Fourteen of 
the healthcare professionals reported that they preferred the use of the app over the 
traditional paper based scales. (31)  
 
1.7.3. Apps developed that may be used as a replacement for currently used tools 
Certain apps developed utilise features built into the smartphone itself, such as the light 
emitting diode flashlight, camera and accelerometer. The accelerometer is a device that is 
able to orientate the smartphone in a three-dimensional setting and can be used to 
measure the position or tilt of the device. While these features themselves have not been 
marketed for use in a medical setting by the manufacturer, apps have been developed to 
utilise these features for use in a medical setting, however the app may not have had any 
form of MPI in its development. 
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Pelegris et al (32) in 2010 investigated the potential use of a smartphone in detecting 
heart rate. They developed an app where an individual’s finger would need to be placed 
over the camera of a smartphone, after which a series of images are taken. The images 
were then scanned to greyscale and an average brightness for each image was obtained. 
As blood is pumped to the finger, the increase in blood volume increased absorption of 
light and so reduced the brightness of the image taken by the camera, which is the 
underlying principle of reflectance plethysmography. The algorithm used by the 
smartphone measured peaks of brightness with troughs to calculate heart rate. The 
algorithm used was compared to a pulse oximeter and a two beats per minute error was 
allowed. Samples from a group of 50 people were taken. Heart rates were initially tested 
in a well-lit area. In this scenario, the amount of light absorbed was 46% of the maximum 
the lens was able to absorb. Heart rates measured had an average error of 4.13%. This 
was then repeated in a less poorly lit environment, where 13% of the maximum amount 
of light the lens could absorb was available. The average error in this sample was 4.67%. 
Whether this difference was significant was not mentioned. The authors of this study 
report that they “demonstrated the proof of concept” for the use of a mobile phone in 
detecting heartbeat.  
 
Other studies have since been conducted in an attempt to validate heart rate monitor 
apps. One such study in Taiwan in 2013 compared four heart rate apps (labelled as apps A 
to D) in paediatric patients to that recorded by an ECG monitor. Patients excluded were 
those over the age of 18, premature babies whose fingers or toes were too small to cover 
the camera and light source of the smartphone, patients who were unstable and those 
where informed consent could not be obtained. In this study, 126 patients were included. 
An ECG monitor was connected and two separate sites were measured for each app used, 
the earlobe and either the finger or toe. The pulse rate was measured at each site three 
times. An accurate value was taken to be a heart rate within five beats per minute if the 
recorded pulse was less than 100 beats per min on the ECG or within 5% of the ECG 
recorded pulse if greater than 100 beats per min. According to this definition, patients 
were divided into accurate and inaccurate groups. Patients were also divided into heart 
rates below 120 beats per min or greater than 120 beats per min. A paired-test was used 
to compare the four apps at each site. Three of the apps showed a significant correlation 
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between the pulse rates measured at both finger/toe and earlobe and one (App C) 
showed significant correlation only when measured at the ear lobe (R2 = 0.215 to 0.857, 
p < 0.001 to p = 0.003). App C had a poor correlation at the finger/toe site (R2 = 0.071, 
p = 0.097). Accuracy of the apps was also measured. With regards to accuracy, there were 
significant differences in accuracy between the earlobe and finger/toe sites measured in 
two apps, A and D (p = 0.039 and p < 0.01 respectively). Comparing accuracy with heart 
rates below 120 beats/min, App D had a higher accuracy when measured at the earlobe 
(p = 0.016), whilst no significant differences amongst accuracy was found amongst the 
other apps. When the heart rate was above 120 beat/min, accuracy dropped in most 
apps, and when measured at the finger/toe site, accuracy was less than 50% for all the 
apps. (33). This study suggests that the capability of a smartphone app to measure heart 
rate does exist, however it is not a practical function at present. 
 
A study by Wackel et al (34) also attempted to validate apps that measure heart rate. Two 
apps were “arbitrarily selected” from the free apps available, both requiring the finger to 
be placed over the camera and light source. Patients undergoing electrophysiology 
studies, performed under general anaesthesia and who were under the age of 18 were 
included in this study, with a total number of 26 being enrolled. A baseline heart rate was 
measured with each app and compared to that on the ECG. After induction of a sustained 
tachycardia, both apps were again used to measure heart rates. If no result was obtained 
after two attempts, it was considered a failure of the app. Some measurements could not 
be made due to spontaneous abortion of the patients’ supraventricular tachycardia. At 
baseline, 34 measurements were made, 33 of which were within 4 beats per min of the 
ECG (r = 0.99). A sustained tachycardia was initiated and 38 attempts to measure heart 
rate were made. The first app only obtained a reading in 10 attempts out of 21 (Pearson 
correlation = 0.56). App 2 only obtained a reading in 5 of 17 attempts (Pearson correlation 
= -0.43). Neither app was found to be accurate enough for use in a clinical setting. 
 
McManus et al (35) utilised the potential for reflectance photoplethysmography not to 
measure the heart rate, but to detect whether there was an irregular pulse. In order to 
achieve this they utilised two statistical techniques; root mean square of successive 
differences of RR intervals (RMSSD), and Shannon entropy, both of which were 
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incorporated into an app developed by the researchers. Patients included in this study 
were those being admitted for elective cardioversion for atrial fibrillation. Those who had 
ECG confirmation of atrial fibrillation were deemed eligible for the study, of which there 
were 76. These patients then placed their fingers over the camera to determine if an 
irregular pulse could be detected by the app. After the elective cardioversion was 
performed, patients who achieved successful cardioversion (the number of which were 
not mentioned) were tested again with the app. This particular algorithm was found to 
have excellent sensitivity (RMSSD = 0.9818, Shannon entropy = 0.975 and combined = 
0.9619), specificity (RMSSD = 0.915, Shannon entropy = 0.8218 and combined = 0.9752) 
and accuracy (RMSSD = 0.9533, Shannon entropy = 0.9097 and combined = 0.9676).  
 
For orthopaedics, a study by Franko, Bray & Newton (36) evaluated an app that assessed 
a patient for scoliosis and compared it to a scoliometer. The scoliometer used was 
attached to the back of an iPhone 4S. This was done so that a reading could be taken by 
two examiners at the same time, each using one of the two devices. The devices were 
rotated through randomly selected angles from -30° to +30°. Four different observers; an 
attending, a fellow, a resident and a nurse practitioner; made 60 measurements each, for 
a total of 240 for each device. There was significant correlation between each individual 
observer with the two devices (Pearson correlation coefficients of r = 0.9994 to 0.9996, 
and p < 0.001 for each observer).   
 
In Melbourne, Australia, an app for testing the range of motion at the hip was assessed. 
This app was also developed by one of the co-authors, and utilised the accelerometer 
built into the phone. A 3-dimensional motion analysis system and bubble inclinometer 
was used to compare the effectiveness of the phone. Twenty healthy participants were 
then recruited into the study and range of motion was conducted by a single 
physiotherapist. For each of seven range of motion test done, three trials were conducted 
on each patient with the median value used for analysis and intra-class correlation 
coefficients used to correlate the three different methods. The reported intra-correlation 
coefficients of the smartphone compared to the 3-dimensional motion analysis was 
greater than 0.85 for each range of motion compared to the 3-dimensional motion 
analysis with the exception of one (ICC = 0.71). There were statistically significant 
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differences for three range of motion tests, which included the range of motion with the 
lowest correlation. (37) 
 
1.7.4. Apps designed to act as an accessory to a currently existing tool 
Apps can also be used as an adjunct to currently existing medical devices or tools. One 
such example was the development of an app linked to a pulse oximeter at the University 
of British Columbia in Vancouver (38). An iPod Touch® was connected to a certified Xpod® 
OEM pulse oximeter and software was developed by the researchers that allowed for the 
heart rate, oxygen saturation and respiratory rate to be visualised on the device’s screen. 
This study was conducted in two phases. Phase one was a usability study amongst 20 
participants (in the University of British Columbia) and features were reviewed by the 
participants. A series of tasks which were standardised were also conducted to assess 
usability and the time taken for each task recorded and then an additional questionnaire 
was given to assess the features of the app. Features that were not favourably viewed, 
such as the tab for changing the settings, were then altered despite an overall satisfaction 
of 82% was found. The second phase of the study was conducted in a Ugandan hospital, 
where participants were recruited by word of mouth. This setting was chosen to view the 
usability of the app and connected hardware in an environment where there was a 
paucity of available pulse oximeters and many surgeries are conducted without them. 
Overall satisfaction was 78% in this group. Time to completion of tasks set out during app 
use was less for the Ugandan portion of the study, as features not found to be favourable 
had been changed. Whether this decrease in time was significant was not mentioned. 
 
Apps and additional attachments can be used to monitor patients remotely, as was 
reviewed in a study in Korea (39) utilising a glucometer linked smartphone app. With this 
app, patients can take their glucose levels and the app would synchronise the readings 
collected into a database that could be viewed by medical staff. Medical staff would 
review the data collected and make recommendations specifically for that patient. This 
was done on a weekly basis. The aim of this study was to assess how effective the 
smartphone app was for glucose monitoring and the interactive communication between 
patient and medical staff. Patients between the ages of 20 and 70, who were type two 
diabetics for more than one year were asked to participate. Thirty-five were included, 
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with a control group also consisting of 35 patients. This study was conducted over a 12 
week period, after which patients were requested to complete a satisfaction 
questionnaire. Patients were then divided into two groups, “satisfied” and “not-satisfied”. 
No significant decrease in HbA1c (p = 0.077) occurred in the study group. The group of 
patients who were satisfied with how the app functioned included 27 patients, and taking 
into account only these patients, there was a significant decrease in HbA1c levels from a 
baseline of about 7.7% ± 0.8% to 7.3% ± 0.6% (p < 0.001). Evaluating the less satisfied 
group, the HbA1c levels increased to 8.1% ± 0.5%, although this was not significant 
(p = 0.062).  
 
1.7.5. Difficulties in assessing apps 
Difficulty in evaluating these studies for are described below: 
 Not all apps reviewed are within a defined category, such as only a calculator or only 
as a screening tool 
 Some studies randomly chose which apps they were to use 
 Some studies chose to evaluate individual apps and so comparison between others 
claiming to do the same may not be as effective, or possibly may have had better 
results 
 Some studies did not give the names of the apps used, and so further investigations 
comparing them cannot be done 
 Some apps were developed specifically for the study itself and then removed from the 
store once completed 
 
Published in the British Medical Journal in September 2013 is a news story of three 
doctors who are accused of plagiarising content in an app they have developed. In 
addition, two of these doctors are accused of “dishonestly posting favourable reviews of 
the app on the Apple iTunes Store”. (40) This is potentially another factor that could 
impede further development of useful apps. 
] 
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1.8. Summary 
These studies reveal that of the myriad of potential apps available for use by a medical 
professional or by a patient, they may not have any form of MPI, be it a clinician or an 
institute, nor may they contain current or even correct information. Conversely, a number 
of apps have been validated for use as a new tool or even one that could replace an 
existing tool. The difficulty arises in that there is currently no method or system in place 
that would allow for a medically related app to be properly evaluated for use in a medical 
setting.  
 
Regulation of apps currently remains ambiguous and difficult to interpret, with the 
resulting possibility existing that an app may be released without proper regulations being 
enforced. The possibility also exists that a potentially useful app may be excluded from 
use. 
 
Smartphone apps have the potential to influence medical practice, by assisting both 
patients and physicians. They have the potential to allow for diseases to be screened for, 
remote monitoring of a patient’s condition and to assist a physician in their practice in a 
near limitless array of functions. 
  
  
23 
 
References  
1. Payne KB, Wharrad H, Watts K. Smartphone and medical related app use among 
medical students and junior doctors in the United Kingdom (UK): a regional survey. BMC 
Medical Informatics and Decision Making. 2012;12:121. DOI:10.1186/1472-6947-12-121 
2. O'Reilly MK, Nason GJ, Liddy S, Fitzgerald CW, Kelly ME, Shields C. DOCSS: doctors on-
call smartphone study. Irish Journal of Medical Science. 2013 Dec;183(4):573-7. 
DOI:10.1007/211845-013-1053-4 
3. O'Connor P, Byrne D, Butt M, Offiah G, Lydon S, Mc Inerney K, et al. Interns and their 
smartphones: use for clinical practice. Postgraduate Medical Journal. 2014 Feb;90(1060):75-9. 
DOI:10.1136/postgradmedj-2013-131930 
4. Wallace S, Clark M, White J. 'It's on my iPhone': attitudes to the use of mobile 
computing devices in medical education, a mixed-methods study. British Medical Journal Open. 
2012;2(4). DOI 10.1136/bmjopen-2012-001099 
5. Franko OI, Tirrell TF. Smartphone app use among medical providers in ACGME training 
programs. Journal of Medical Systems. 2012 Oct;36(5):3135-9. DOI:10.1007/s10916-011-9798-7 
6. Nason GJ, Burke MJ, Aslam A, Kelly ME, Akram CM, Giri SK, et al. The use of smartphone 
applications by urology trainees. The Surgeon: Journal of the Royal Colleges of Surgeons of 
Edinburgh and Ireland. 2015Oct;13(5):263-6). DOI: 10.1016/j.surge.2014.06.008 
7. Ventola CL. Mobile devices and apps for health care professionals: uses and benefits. P 
& T : A Peer-reviewed Journal for Formulary Management. 2014 May;39(5):356-64. PMID: 
24883008 
8. O'Neill S, Brady RR. Colorectal smartphone apps: opportunities and risks. Colorectal 
disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland. 
2012 Sep;14(9):e530-4. DOI:10.1111/j.1463-1318.2012.03088.x 
9. Carter T, O'Neill S, Johns N, Brady RR. Contemporary vascular smartphone medical 
applications. Annals of Vascular Surgery. 2013 Aug;27(6):804-9. DOI:10.1016/j.avsg.2012.10.013 
10. Zaki M, Drazin D. Smartphone use in neurosurgery? APP-solutely! Surgical Neurology 
International. 2014;5:113. DOI:10.4103/2152-7806.137534 
11. Mobasheri MH, Johnston M, King D, Leff D, Thiruchelvam P, Darzi A. Smartphone breast 
applications - What's the evidence? Breast. 2014 Oct;23(5):683-9. 
DOI:10.1016/j.breast.2014.07.006 
12. Edlin JC, Deshpande RP. Caveats of smartphone applications for the cardiothoracic 
trainee. The Journal of Thoracic and Cardiovascular Surgery. 2013 Dec;146(6):1321-6. 
DOI:10.1016/j.jtcvs.2013.08.033 
13. Cantudo-Cuenca MR, Robustillo-Cortes MA, Cantudo-Cuenca MD, Morillo-Verdugo R. A 
better regulation is required in viral hepatitis smartphone applications. Farmacia Hospitalaria: 
Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2014 
Mar-Apr;38(2):112-7. DOI:10.7399/FH.2014.38.2.1125 
14. Haffey F, Brady RR, Maxwell S. A comparison of the reliability of smartphone apps for 
opioid conversion. Drug safety: An International Journal of Medical Toxicology and Drug 
Experience. 2013 Feb;36(2):111-7. DOI:10.1007/s40264-013-0015-0 
15. Cheng NM, Chakrabarti R, Kam JK. iPhone applications for eye care professionals: a 
review of current capabilities and concerns. Telemedicine Journal and e-health: The Official 
Journal of the American Telemedicine Association. 2014 Apr;20(4):385-7. 
DOI:10.1089/tmj.2013.0173 
16. Visvanathan A, Hamilton A, Brady RR. Smartphone apps in microbiology--is better 
regulation required? Clinical Microbiology and Infection: The Official Publication of the 
European Society of Clinical Microbiology and Infectious Diseases. 2012 Jul;18(7):E218-20. 
DOI:10.1111/j.1469-0691.2012.03892.x 
24 
 
17. U.S. Department of Health and Human Services Food and Drug Administartion. Mobile 
Medical Applications: Guidance for Industry and Food and Drug Administration Staff. U.S. 
Department of Health and Human Services Food and Drug Administration, 2015. 
18. European Commission. Medical Devices: Guidance Document. European Commission, 
January 2012. 
19. Medicines Control Council. Medical Devices and IVDs Essential Principles. South Africa: 
Medicines Control Council, September 2014. 
20. Sherwyn-Smith J, Pritchard-Jones R. Medical Applications: The Future of Regulation. 
Royal Colleges of Surgeons of England. 2012;94:12-3. DOI:10.1308/147363512X13189526438512 
21. iMedicalApps. iMedicalApps - About [Accessed 10 October 2014]. Available from: 
www.imedicalapps.com/about/. 
22. Happtique. Happtique.com [Accessed 12 October 2014]. Available from: 
https://www.happtique.com/. 
23. MobiHealthNews. Happtique suspends mobile health app certification program 
[Accessed 19 October 2014]. Available from: http://mobihealthnews.com/28165/happtique-
suspends-mobile-health-app-certification-program/. 
24. iMedicalApps. Exclusive: Apple now asking app developers to provide sources of 
medical information 2013 [Accessed 12 October 2014]. Available from: 
http://www.imedicalapps.com/2013/09/apple-app-developers-sources-medical-information/. 
25. Eysenbach G, Payne K, Wharred H, Bierbier R, Lo V, Wu R. Evaluation of the Accuracy of 
Smartphone Medical Apps. Journal of Medical Internet Research. 2014;16(2). Epub 03 February 
2014. DOI:10.2196/jmitr.3062 
26. Morris R, Javed M, Bodger O, Hemington Gorse S, Williams D. A comparison of two 
smartphone applications and the validation of smartphone applications as tools for fluid 
calculation for burns resuscitation. Burns: Journal of the International Society for Burn Injuries. 
2014 Aug;40(5):826-34. doi.org/10.1016/j.burns.2013.10.015 
27. Flannigan C, McAloon J. Students prescribing emergency drug infusions utilising 
smartphones outperform consultants using BNFCs. Resuscitation. 2011 Nov;82(11):1424-7. 
DOI:10.1016/j.resuscitation.2011.07.014 
28. Wolf JA, Moreau JF, Akilov O, Patton T, English JC, 3rd, Ho J, et al. Diagnostic inaccuracy 
of smartphone applications for melanoma detection. JAMA Dermatology. 2013 Apr;149(4):422-
6. DOI:10.1001/jamadermatol.2013.2382 
29. BinDhim NF, Shaman AM, Trevena L, Basyouni MH, Pont LG, Alhawassi TM. Depression 
screening via a smartphone app: cross-country user characteristics and feasibility. Journal of the 
American Medical Informatics Association: JAMIA. 2014 Oct; 0:1–5. DOI:10.1136/amiajnl-2014-
002840 
30. Bajaj JS, Thacker LR, Heuman DM, Fuchs M, Sterling RK, Sanyal AJ, et al. The Stroop 
smartphone application is a short and valid method to screen for minimal hepatic 
encephalopathy. Hepatology. 2013 Sep;58(3):1122-32. DOI:10.1002/hep.26309 
31. de la Vega R, Roset R, Castarlenas E, Sanchez-Rodriguez E, Sole E, Miro J. Development 
and testing of painometer: a smartphone app to assess pain intensity. The Journal of Pain: 
Official Journal of the American Pain Society. 2014 Oct;15(10):1001-7. 
DOI:10.1016/j.jpain.2014.04.009 
32. Pelegris P, Banitsas K, Orbach T, Marias K. A novel method to detect heart beat rate 
using a mobile phone. Conference proceedings : Annual International Conference of the IEEE 
Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society 
Annual Conference. 2010;2010:5488-91. DOI:10.1109/IEMBS.2010.5626580 
33. Ho CL, Fu YC, Lin MC, Chan SC, Hwang B, Jan SL. Smartphone applications (apps) for 
heart rate measurement in children: comparison with electrocardiography monitor. Pediatric 
Cardiology. 2014 Apr;35(4):726-31. DOI:10.1007/s00246-013-0844-8 
25 
 
34. Wackel P, Beerman L, West L, Arora G. Tachycardia detection using smartphone 
applications in pediatric patients. The Journal of Pediatrics. 2014 May;164(5):1133-5. 
DOI:10.1016/j.jpeds.2014.01.047 
35. McManus DD, Lee J, Maitas O, Esa N, Pidikiti R, Carlucci A, et al. A novel application for 
the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation. Heart 
Rhythm: The Official Journal of the Heart Rhythm Society. 2013 Mar;10(3):315-9. 
DOI:10.1016/j.hrthm.2012.12.001 
36. Franko OI, Bray C, Newton PO. Validation of a scoliometer smartphone app to assess 
scoliosis. Journal of Pediatric Orthopedics. 2012 Dec;32(8):e72-5. 
DOI:10.1097/BPO.0b013e31826bb109 
37. Charlton PC, Mentiplay BF, Pua YH, Clark RA. Reliability and concurrent validity of a 
Smartphone, bubble inclinometer and motion analysis system for measurement of hip joint 
range of motion. Journal of Science and Medicine in Sport / Sports Medicine Australia. 2014 
Apr;18(3):262-7. DOI:10.1016/j.jsams.2014.04.008 
38. Hudson J, Nguku SM, Sleiman J, Karlen W, Dumont GA, Petersen CL, et al. Usability 
testing of a prototype Phone Oximeter with healthcare providers in high- and low-medical 
resource environments. Anaesthesia. 2012 Sep;67(9):957-67. DOI:10.1111/j.1365-
2044.2012.07196.x 
39. Kim HS, Choi W, Baek EK, Kim YA, Yang SJ, Choi IY, et al. Efficacy of the smartphone-
based glucose management application stratified by user satisfaction. Diabetes & Metabolism 
Journal. 2014 Jun;38(3):204-10. DOI:10.4093/dmj.2014.38.3.204 
40. Dyer C. Doctors are accused of plagiarising a medical guide to produce a smartphone 
app. BMJ. 2013;347:f5426. DOI: 10.1136/bmj.f5426 
 
 
  
26 
 
Section 2: Journal of Medical Internet Research author guidelines 
 
This section was included to highlight the guidelines set out by the Journal of Medical Internet 
Research for a draft article, which is the intended journal for submission of this article. 
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Instructions for Authors of JMIR 
For general information about the structure and content of a biomedical manuscript, 
authors should become familiar (skim through) the  ICMJE Uniform Requirements for 
Manuscripts before reading the specific instructions for JMIR authors below. 
 Types of Papers That May Be Submitted 
 Format for Original Articles 
o Sample Template 
o Abstract 
o Keywords 
o References 
o  
 Archive cited web references with WebCite 
(www.webcitation.org) 
o Abbreviations 
o Multimedia Appendix 
 Figures and Tables 
 Table of Contents Image 
 Important Notes on Reporting P values 
 Novel Article Components 
 Online Submissions 
o Web-Based Manuscript Submission and Tracking System 
o Title Page 
o Acceptable Languages 
o Checklist 
o Cover Letter 
o Peer-Reviewer Nominations for your submission 
o Fast-Track Review and Premium Publishing: publication of your 
article within 4 weeks - guaranteed! 
 Editorial Processes 
o Speed of Peer Review 
o Criteria for Selection of Manuscripts 
o Ethical Issues 
o Routine Checking for Plagiarism 
 Open Access Model, Fee Schedule  
 Open Publication License, Authorship Responsibility, Declaration of Competing 
Interests 
The Journal of Medical Internet Research (JMIR) and its sister journals are innovative, 
international, peer-reviewed medical journals that aim to publish articles relevant for 
medical professionals, system developers, and system users alike. 
These instructions for authors are valid for all JMIR journals. Instructions for authors are 
subject to frequent revision. Please look them over carefully before submitting your 
manuscript. 
Manuscripts are considered with the understanding that they have not been published 
previously in print or electronic format and are not under consideration by another print 
or electronic publication. A complete report following a presentation at a meeting or the 
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publication of preliminary findings elsewhere (eg, in an abstract) will be considered. 
Material that has been published on the Internet can also be considered, but any previous or 
simultaneous publication on the Internet must be disclosed in the cover letter. Include 
copies of potentially duplicative material that has been previously published or is currently 
being considered elsewhere, and provide links to duplicative material on the Internet. Point 
out possible overlaps with previously published or simultaneously submitted articles in 
your cover letter. Note that "duplicate publication or the submission of duplicate material is 
not necessarily unethical, but failure to disclose the existence of duplicate articles, 
manuscripts, or other material is unethical and may represent a violation of copyright 
material." (AMA Manual of Style, 9th ed, p. 98). A content overlap of just 10% may be 
considered duplicative. 
JMIR reserves the right to bill authors for the peer-reviewing, copyediting, layout, and 
publishing costs of articles which need to be retracted during the production process or 
after publication on grounds of redundant publication, copyright infringements, or other 
forms of scientific misconduct. 
  
Types of Papers That May Be Submitted 
We accept the following: 
 original papers (see format below) 
 short papers (original article < 1500 words) 
 viewpoints (opinion and discussion papers)  
 consensus papers 
 reviews 
 tutorials 
 case reports 
 policy papers, proposals 
 commentaries 
 book/software reviews 
 research protocols and grant proposals (now published in our new spin-off 
journal JMIR Research Protocols) 
 letter to the editor (ONLY in response to a previous publication in JMIR, which 
must be cited as first reference) [exempt from Article Processing Fee] 
Please indicate the intended type of paper on your cover page. 
We have no rigorous space restrictions for any of these papers, except for the short paper. 
However, we urge authors to be concise. A typical paper contains between 3000 and 6000 
words. 
In addition, all papers must contain the following sections: Abstract (see abstract 
format below), Keywords, Main article body (see below for original articles), 
Acknowledgements, Conflicts of Interest, References. 
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Acknowledgements, Conflicts of Interest 
A description of sources of funding, financial disclosure, and the role of sponsors must be 
included in the Acknowledgements section of the manuscript. This description should 
include the involvement, if any, in review and approval of the manuscript for publication 
and the role of sponsors. 
In addition, authors must disclose in a Conflicts of Interest section if they have personal 
financial interests related to the subject matters discussed in the manuscript. It is not 
unusual for JMIR authors to be, for example, owners or employees of Internet companies 
that market the services described in their manuscript. There is nothing wrong with this, 
but editors, reviewers, and readers should be made aware of such conflicts of interests; 
thus, these facts must be disclosed. 
  
  
Format for Original Papers 
Papers should be written in accordance with the American Medical Association Manual of 
Style: A Guide for Authors and Editors. 9th ed. Baltimore, Md: Williams & Wilkins; 1998. 
 The following format ("IMRAD Format") must be used for the paper: 
 Abstract (not exceeding 450 words for structured abstracts, see abstract 
format below) 
 Keywords - see Keywords 
 Introduction (eg, theory, hypotheses, prior work) 
 Methods (eg with the subheadings "Recruitement", "Statistical Analysis", etc.) 
 Results (eg, user statistics, evaluation outcomes). If your study consists of different 
stages/parts, subheadings in this section should mirror subheadings in the methods 
section to describe these parts. 
 Discussion (eg, with the subheadings "Principal Results", "Limitations", 
"Comparison with Prior Work", "Conclusions") 
 Acknowledgements 
 Conflicts of Interest 
 [optional] Multimedia Appendix of supplementary files (eg, a PowerPoint 
presentation of a conference talk about the study, additional screenshots of a 
website, mpeg/Quicktime video or audio files, or Excel, Access, SAS, or SPSS files 
containing original data) - see Multimedia Appendix 
 References - see References 
 Abbreviations - see Abbreviations 
Please use subheadings within the main "Introduction," "Methods," "Results," and 
"Discussion" sections. For example, if you describe three different methods, use three 
subheadings within the "Methods" section. Also, use matching subheadings in the 
"Results" section if you report the results from each of the described methods. 
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Randomized controlled trials (RCTs) are highly welcome and should be reported in 
accordance with the  CONSORT statement. A  diagram illustrating the flow of 
participants through the trial is required. 
JMIR is now pilot-testing a CONSORT-EHEALTH checklist - please download the 
checklist from http://www.jmir.org/ojs/public/journals/1/CONSORT-EHEALTH-v1-
6.pdf . Although this is primarily intended for randomized trials, the section of the 
checklist describing how an intervention should be reported is also relevant for 
manuscripts with other evaluation designs. 
Before submission, authors of RCTs must fill in the electronic CONSORT-EHEALTH 
questionnaire at http://tinyurl.com/consort-ehealth-v1-6 with quotes from their 
manuscript (if you wish to comment on the importance of the items from the checklist for 
reporting, please also rate each item on a scale between 1-5). BEFORE you press submit, 
please generate a pdf of the form with your responses and upload this file as supplementary 
file entitled CONSORT-EHEALTH V1.6. 
A CONSORT-flowdiagram and a attrition diagram are also strongly recommended (as 
figures). 
In accordance with ICMJE recommendations, RCTs must have been registered in a 
WHO accredited trial registry. Please mention the ClinicalTrials.gov registration 
identifier, the   International Standard Randomized Controlled Trial Number (ISRCTN), 
or a comparable trial identifier at the end of the abstract ("Trial Registration: 
ClinicalTrials.gov NCT123456"), as well as when you first mention the trial in the 
manuscript. When mentioning related trials (e.g. in the Introduction or Methods section) 
the trial registration number should also be added in brackets. ICMJE member journals 
require, as a condition of consideration for publication, registration in a public trials 
registry at or before the onset of patient enrollment. This policy applies to any trial 
which started enrollment after July 1, 2005. JMIR authors must add an explanation 
to the methods section of their manuscript if a RCT meeting these criteria has not 
been registered. The JMIR editor reserves the right to reject any paper without trial 
registration without any further consideration or peer-review. 
Meta-analyses and systematic reviews are also highly welcome and should be reported in 
accordance with the  QUORUM statement. 
  
Sample Template 
A Word-template of an article compatible with journals from JMIR Publications can be 
downloaded 
from http://jmir.org/ojs/public/journals/1/InstructionsForAuthorsOfJMIR.docx. Note that 
the references can be in any format, as long as the in-text citations are sequentially 
numbered in the manuscript with square brackets and as long as the reference at the end 
has a PMID in the format PMID:123456. 
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Abstract Format 
The abstract for an original paper, systematic review, or consensus paper must not exceed 
450 words and must be structured, using the following sections: 
 Background 
 Objective 
 Methods 
 Results (make sure to include relevant statistics here, such as sample sizes, 
response rates, P-values or Confidence Intervals. Do not just say "there were 
differences between the groups") 
 Conclusions 
 (Trial ID number, e.g. ISRCTN, for RCTs) 
For further details on structured abstracts, see  http://jama.ama-
assn.org/info/auinst_abs.html. 
Proposals, comments, tutorials, reviews, and other types of papers may contain an 
unstructured abstract (max. 500 words). 
  
Keywords 
Below the abstract, authors should provide 3 to 10 keywords or short phrases that will 
assist indexers in cross-indexing the article and that may be published with the abstract. 
Terms from the medical subject headings (MeSH) list of Index Medicus should be used  
(see  http://www.nlm.nih.gov/mesh/MBrowser.html). As well, keywords from ACM's 
Computing Classification System may be used if suitable MeSH terms are not available. 
  
References 
 Include a reference list (numbered 1., 2., 3. etc.) at the end of the paper. While in-
text references are in square brackets [1], the bibliography at the end of the text 
must be numbered 1., 2., 3. etc (no square brackets).  
 Do not use the footnote or endnote tool of your word processor to generate the 
reference list. Articles which contain footnotes as references may be returned 
without peer review. 
 Cite only published or accepted ("in print") work as reference. Submitted papers 
(not yet accepted for publication), documents not widely available (personal emails, 
letters), or oral communications (unless they are published as abstract) should not 
be cited as reference, but instead must be cited in the main body of text as 
"personal communication by NAME, DATE". Obtain the permission of the 
communicator to quote his communication. 
 Remove OLE Elements from reference management software (e.g. Endnote, 
Reference Manager):  
OLE elements typically appear if authors use refman or endnote to manage their 
bibliography. OLE elements can be recognized by e.g. clicking on a in-text citation 
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and/or the bibliography - if they have a grey background, it is an OLE document 
(and if you insert a comment for a certain reference, the entire reference block 
appears commented). OLE elements may also appear if you number table labels 
automatically, cross-reference to objects in the documents etc.).  
In all these cases you must convert your manuscript to a plain text document before 
we can copyedit it.  
Please remove any OLE elements from your manuscript before submission (keep 
the original file and create a copy with field codes removed). To convert references 
added by Reference Manager or Endnote to plain text, you can use the program 
itself to remove the OLE codes (for RefMan the menu point is Tools -> RefMan -> 
Remove Field Codes). 
 Make sure that your references are correct by using the PubMed Citation 
Matcher. 
 New (12/2010): For Medline indexed references, we now ask that you append 
the PubMed Identifier (PMID) after each reference, e.g. "PMID:1234567" 
(where 1234567 is the pubmed identifier) at the end of a reference. Alternatively 
(as per our old instructions) you could append a [Medline] link after each reference, 
linking to the PubMed abstract of the article you are citing. Alternatively, 
just  Information on how to do this can be found in the document How to insert 
Medline Links [PDF document]. During copyediting, we now use a web-based 
reference checking software (OrangeX) which will match your references to 
references in Medline and automatically correct them. If you have a PMID or 
Medline link after each reference, this process will work smoothly and formatting 
errors of references will be automatically corrected. 
 If references are not listed in PubMed, please try to identify the DOI (digital 
object identifier) and add the DOI at the end of the reference (e.g. 
doi:10.1136/bmj.331.7529.1391). The DOI is a unique identifier which is published 
by most journals somewhere within the article. You may check whether a DOI is 
correct using the DOI resolver at http://dx.doi.org/. 
 For books, please add the ISBN, if known (no blanks). See 
e.g. http://isbndb.com/ 
 Number references in the order they appear in the text; do not alphabetize. 
 Identify references within the body of the paper with Arabic numerals enclosed in 
square brackets (eg, [1,2]). Do not use superscripts. 
 References must comply with JMIR style (see examples below).  
 Websites and Web articles (URLs) should be cited as "webcited
®
" references in 
the reference section at the end of the manuscript - do not include links to websites 
in the text. To webcite
®
 a web reference means to take a snapshot of the cited 
document and to cite the archived copy (WebCite link) in addition to the 
original URL. JMIR now requires that authors use the WebCite 
®
 technology 
(www.webcitation.org) to archive cited web references first before they cite them. 
Do not cite uncached "live" webpages and websites in the article or reference 
section, unless archiving with WebCite has failed. Provide the original URL, the 
WebCite link, and an access date, which should be the date you cached the web 
reference (see Web references archived with WebCite below). 
 Use Medline abbreviations for journal titles (see PubMed Journal Browser). 
Journal Articles: 
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Preferred format since 12/2010 (including the PMID leads to better results as during 
production our RefCheck script will clean up and autocorrect the references): 
Westberg EE, Miller RA. The basis for using the Internet to support the information needs 
of primary care. J Am Med Inform Assoc 1999 Jan-Feb;6(1):6-25. PMID:9925225 
International Committee of Medical Journal Editors. Uniform requirements for 
manuscripts submitted to biomedical journals. JAMA 1997;277:927-934. PMID:9062335 
  
(old format with link to Pubmed handing over the PMID, now discouraged) 
Westberg EE, Miller RA. The basis for using the Internet to support the information needs 
of primary care. J Am Med Inform Assoc 1999 Jan-Feb;6(1):6-25. [Medline] 
International Committee of Medical Journal Editors. Uniform requirements for 
manuscripts submitted to biomedical journals. JAMA 1997;277:927-934. [Medline] 
  
Books: 
Iverson CL, Flanagin A, Fontanarosa PB, et al. American Medical Association Manual of 
Style: A Guide for Authors and Editors. 9th edition. Baltimore, Md: Williams & Wilkins; 
1998. ISBN:0195176332 
Conference proceedings: 
Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings 
of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; 
Kyoto, Japan. Amsterdam: Elsevier; 1996. 
Note: If conference proceedings are available through Medline, please use the Medline 
citation rather than the style above - for example in case of AMIA proceedings or IMIA 
proceedings (=Medinfo) the citation is as follows: 
Mandl KD, Kohane IS. Healthconnect: clinical grade patient-physician communication. 
Proc AMIA Symp 1999;(1-2):849-53. PMID: 10566480 
Hachem F, Bellet J, Flory A, Leverve X. A generic model for Internet-accessed databases 
in epidemiology: a nutritional application. Medinfo 1998;9 Pt 2:1310-3.  
Chapter in a Book: 
Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. 
Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven 
Press; 1995. p. 465-78. 
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Web references (webpages, grey/government reports available on the web as PDFs, 
etc.) 
See below: all webreferences (webpages, PDF reports) must be archived with WebCite. 
And both the original URL and the WebCite URL must be provided. If you cite reports 
(such as Pew Internet reports, government reports, etc.), try to locate a free PDF on the 
web and cite/webcite the PDF version. 
Journal article in electronic format: 
Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis 1995 Jan-
Mar; 1(1):[24 screens]. http://www.cdc.gov/ncidod/EID/eid.htm 
[do NOT add WebCite links to journal articles]  
  
Web References archived with WebCite 
®
 
As cited URLs tend to disappear months or years after citing online material, JMIR 
now requires that (instead of citing "live" webpages and websites in the article) authors use 
the WebCite 
®
 technology (www.webcitation.org) to archive cited web references first 
before they cite them. Please go to www.webcitation.org and enter the URL you want to 
cite. The system will take a "snapshot" of the webpage or online document (e.g. pdf) so 
that it will remain available for future readers. WebCite will also give you detailed 
instructions on how to cite the web reference. Electronic journal articles SHOULD NOT 
be archived with WebCite if they can be expected to be "stable" e.g. available in libraries 
and/or carry a DOI, but all other material which might disappear in the future should be 
archived first by the citing author. For further information on WebCite see also the 
article Going, Going, Still There: Using the WebCite Service to Permanently Archive 
Cited Web Pages, J Med Internet Res 2005, 12, 30; 7(5):e60. 
Example for Citing a Web Reference 
Preferred format for submissions to JMIR (note that the access/archiving date does not 
need to be provided because it can be retrieved by the reader when clicking on the 
WebCite link: 
Fox S, Fallows D. 2003. Internet Health Resources. 
http://www.pewinternet.org/pdfs/PIP_Health_Report_July_2003.pdf . Archived at: 
http://www.webcitation.org/5I2STSU61 
The access date will be automatically added during copyediting.  
Abbreviations 
All acronyms/abbreviations (including common ones such as WWW and HTML) must be 
explained in parenthesis after their first occurrence. If many unfamiliar 
acronyms/abbreviations are used, please compile them in an "Abbreviations"section at 
the end of the paper. 
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Multimedia Appendix 
We strongly encourage to append multimedia appendices, for example research 
instruments (questionnaires), movie files including screencasts, a Powerpoint file 
containing additional screenshots or slides from a talk about the study, a Word, RTF, or 
PDF document showing the original instrument(s) used, a video, or the original data 
(SAS/SPSS files, Excel files, Access Db files etc.). Do not include copyrighted material 
unless you obtained writte permission from the copyright holder, which should be faxed to 
the editorial office in case of acceptance together with your Publication Agreement form. 
Multimedia Appendices intended for publication must be numbered and referred to in the 
manuscript. Provide in-text citations (for example "see Multimedia Appendix 1") as well as 
a section with the heading "Multimedia Appendix" before the "References" section. Here, 
list all Multimedia Appendices and include a brief caption line for each Mutlimedia 
Appendix describing its contents. 
Multimedia Appendices must be uploaded as "supplementary files" during the submission 
process. In the submission form, carefully enter the caption of the Appendix in a 
publishable format (using the correct case and avoiding typos and abbreviations), as this 
will be used in the final publication. 
Supplementary files for editor/reviewer eyes only (e.g. related publications) can also be 
uploaded as "other supplementary file") - these are NOT referred to as "Mutlimedia 
Appendix". 
Figures and Tables 
Include all figures and tables in the manuscript at the location where they should 
appear in the final manuscript. 
Screenshots of the intervention/website as a figure or a movie file of the intervention (as 
Multimedia Appendix, see above) are highly encouraged. 
Figures and captions remain in the manuscript during peer-review, but will be removed 
during production, using the files and captions uploaded separately from the manuscript. 
Please also upload each of your final figure (and multimedia appendix) as supplementary 
file  (hi-resolution png or jpg files with minimal compression). DO NOT upload .doc files 
with lineart or other file formats as figure. Movie files (.m4v, .avi etc.), powerpoint files 
(.ppt), or documents (pdf/.doc) should be uploaded and referred to as Multimedia 
Appendix (see above), not figures. Please name your files so that it becomes clear what 
version/revision the figure refers to, e.g. fig1_rev20090130.png. Enter the caption (which 
will appear underneath the figure) online, omitting the figure label ("Figure 1"), as this will 
be added automatically. Remove figure label and captions from the image file, if present. 
Note that for the final publication, the caption will be pulled from the metadata, NOT the 
caption provided in the manuscript. 
IMPORTANT (and new since Aug 2011): During production, FIGURE AND 
MULTIMEDIA APPENDIX CAPTIONS FOR THE FINAL PUBLICATION ARE NO 
LONGER PULLED FROM THE MANUSCRIPT, INSTEAD, THEY ARE GENERATED 
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FROM OUR DATABASE (what you enter in the field "caption" when you upload a figure 
or appendix). 
When preparing tables, please make sure that for each row you create a new table row, 
rather than writing multiple rows into one cell. Example:  
 
Correct: 
    n (%) 
Age 30-40 23 (43%) 
  40-50 27 (23%) 
Gender Female 80 (40%) 
  Male 120 (60%) 
 
 Wrong: 
   n (%) 
Age 30-40 
40-50 
23 (43%) 
27 (23%) 
Gender Female 
Male 
80 (40%) 
120 (60%) 
  
It is technically not possible to generate different table headers for the same column in the 
course of the same table (e.g. switching from "%" to "mean") - the original table header 
will be automatically repeated on new pages. If the meaning of the column changes, then 
this constitutes a new table with a separate label and caption. If you report different metrics 
for different kinds of data (e.g. % for dichotomous outcomes, means and SD for continuous 
outcomes), write "(mean, SD)" or "(%)" after the category headings, or find alternative 
ways to present the information (e.g. footnotes).  
  
Use portrait format and 10-12 pt fonts for tables. Do not use landscape paper formats 
for tables or smaller fonts to squeeze more information (more columns) into a table. If you 
have too many columns and the table becomes too wide so that you would have to use a 
smaller font, consider breaking the table into multiple tables. We will always typeset tables 
in normal font and in portrait orientation. Tables with too many columns will have very 
narrow columns and look squeezed.  
Footnotes for tables must always be a-z (superscript). Do not use symbols such as * or ** 
(AMA styleguide has recently been revised to that effect - older JMIR articles still use 
symbols). 
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Also, please do not submit tables as separate (supplementary) files - always include them 
in the manuscript file. 
  
Table of Contents Image 
Please upload an "illustrative" figure or photo to be used for our homepage and the table-
of-contents (we call this a "TOC image"). The TOC image should be at least 800px by 
600px (4:3 ratio), with no excessive white space and no border. 
 
Important Notes on Reporting P values 
The actual P value should be expressed (P = .04) rather than expressing a statement of 
inequality (P < .05), unless P < .001. The P value should be expressed to 2 digits whether 
or not it is significant. When rounding, 3 digits is acceptable if rounding would change the 
significance of a value (eg, P = .049 rounded to .05). If P < .01, it should be expressed to 3 
digits. 
P values less than .001 should be reported as P < .001. Expressing P to more than 3 
significant digits does not add useful information since precise P values with extreme 
results are sensitive to biases or departures from the statistical model. 
The traditional reporting of P values (indicating only that P < 0.05) simply indicated 
whether the results were "statistically significant" or not. But P values of 0.051 and 0.049 
should be interpreted similarly despite the fact that the 0.051 is greater than 0.05 and is 
therefore not "significant" and that the 0.049 is less than 0.05 and thus is "significant." 
Reporting actual P values avoids this problem of interpretation. P values should not be 
listed as not significant (NS) since, for meta-analysis, the actual values are important and 
not providing exact P values is a form of incomplete reporting. 
Do not use 0 before the decimal point for statistical values P, alpha, and beta because they 
cannot equal 1. For some statistical values (eg, kappa) even if they cannot ever equal 1, use 
0 if they are used infrequently. 
P is always italicized and capitalized. 
Novel Paper Components: Original Data, Animations, HypER Papers 
As a journal covering innovative methods to disseminate knowledge on the Internet, we 
want to be innovative in our style and format and take advantage of the possibilites 
available by publishing online. We do not want, as many online journals do, to reproduce 
an exact version of a traditional printed journal. 
We therefore encourage you to experiment with novel methods of presentation whenever 
you feel it is appropriate and helps the reader, for example, 
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 animated gifs 
 other media (movies) 
 attachment or link to a database (Access) or spreadsheet (Excel) file containing 
original or additional data 
 JAVA applets 
  
  
Online Submission 
Web-Based Manuscript Submission and Tracking System 
 JMIR uses an online submission and manuscript tracking system. To submit 
your paper, please register as an author (in your user profile) and go the 
author home page. 
 You will have to register as an author and will then be guided through the 
submission process. You may upload your manuscript as an .rtf (rich text) or .doc 
(WinWord) file, as well as supplementary files such as figures. 
 Email submissions are not accepted. 
 This system allows you to check the status of your manuscript at any time. Please 
refrain from sending emails to the editor or journal staff inquiring about the status 
of your manuscript. 
 Upon submission, you will receive an automatic email acknowledging receipt of 
your paper. If you do not receive a response within 24 hours, please verify that the 
paper has been submitted (using the manuscript tracking system). 
  
Title Page 
The first page of your manuscript should be a title page containing the type of paper; the 
title; all authors' names, degrees, and affiliations; and the corresponding author's contact 
address (including phone and fax numbers) and email address. 
  
Acceptable Languages 
Except for supplements covering special topics of regional interest or containing papers 
having been presented at non-English speaking meetings, manuscripts must be English. 
Non-native speakers are advised to seek help from a native speaker or a professional 
copyeditor before submission. Although accepted JMIR manuscripts are also edited for 
language, a poorly written manuscript has lower chances to be accepted, and multiple typos 
and grammatical errors often reflect poorly on the author. 
Final Checklist 
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Before you submit your manuscript to JMIR, make sure that you avoid the following 
common formatting / editorial problems: 
  
A. ( ) all in-text references must be numbers in square brackets like this [1]. Do not use the 
author-year system. Do not use round brackets. Do not use superscript. 
B. ( ) JMIR does not use footnotes or endnotes. If you have footnotes, please delete them 
or incorporate them into the text 
C. ( ) URLs must be cited as references and should be archived using WebCite 
(www.webcitation.org) 
D. ( ) in addition to the WebCite URL, please also mention the original URL in the 
references 
E. ( ) please list only one corresponding author with full address, including phone, fax, and 
email address 
F. ( ) Major headings for ALL original papers must be Introduction - Methods - Results - 
Discussion 
G. ( ) Please add subheadings under Introduction/Methods/Results/Discussion (if you use 
WinWord, apply the style "Heading 2" to IMRD headings, and the styles "Heading 3"  to 
subsequent subheadings). DO NOT USE italics or bold keywords or sentences in 
paragraphs in lieu of subheadings / sub-subheadings. 
H. ( ) You must have more than one subheadings in each section, otherwise please remove 
the subheading 
I. ( ) Your subheadings in the methods section should usually mirror the subeadings in the 
results section (i.e. for each result type there must be an explanation in the methods on how 
these results were obtained) 
J. ( ) please check our Instructions for Authors on how P-values should be reported 
K. ( ) If you want to include a multimedia appendix, please insert a reference ("Multimedia 
Appendix 1: [caption]") with a caption in the manuscript (before "References"), but make 
sure to also upload the Appendix as supplementary file. Each appendix must be uploaded 
as separate file.  
L. ( ) End your introduction with a clear statement of what the aim of this paper or study is, 
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ABSTRACT 
Background: The use of mobile devices and medical software applications (apps) 
for mobile devices have been increasing amongst medical professionals. Medical 
apps can be used for a variety of functions and clinical decisions may be made 
based on the information provided by these apps. However these apps do not 
need to have a medical professional involved in the development before being 
made available for use. Little data could be found regarding app use amongst 
anaesthetists. 
Objectives: To describe anaesthetists in the Department of Anaesthesiology at 
the University of the Witwatersrand’s use of medically related mobile device 
applications and the assessment of the credibility of those most commonly used. 
Methods: Anonymous and self-administered questionnaires, requesting 
demographic data and information regarding apps used, were distributed among 
anaesthetists. From the participants list of apps the five most commonly used were 
assessed against a credibility template.  
Results: A total of 127 questionnaires (61% of the department) were distributed 
with 117 (92.1%) being returned. All participants owned a mobile device, the most 
popular brand being Apple. There were 99 (84.6%) participants who have used a 
medical app in their practice. Differences in app use were seen between different 
age groups, 88.0% in those less than 40 years vs 58.8% in those 40 years or 
older. More females than males (35.1% vs 22.0%) and more participants younger 
than 40 years (31.8% vs 10.0%) used an app daily. Daily use of apps varied from 
0% to 33.3% among participants with different years of experience. The most 
commonly used apps were Medscape (61.6%), ECG Guide (10.1%), Qx Calculate 
(10.1%), The Oxford Handbook of Anaesthesiology (9.1%) and Pedistat (9.1%). 
Recommendation by a colleague influenced the choice of app in 40.9% of 
participants. The five most commonly used apps in the department all appeared 
credible. 
Conclusions: Mobile devices were owned by all participants and 84.6% made use 
of medical apps in their practice. The majority of participants used an app at least 
once a week with the older participants making less use of them. Medscape was 
the most frequently used app. The five most commonly used apps in the 
department all appear credible.  
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Introduction 
The use of mobile devices, that is smartphones and tablet computers (tablets) as 
well as their related software applications (apps), have been increasing in the last 
few years. With this, medically related programs that can be used by both 
clinicians and patients alike have been developed. Within the medical field, mobile 
device use is popular and appears to be increasing. For example in the United 
Kingdom, between 74 to 87% of junior doctors owned a smartphone between 2011 
and 2012 [1-3] increasing to almost 100% in 2013 [4] and 2014 [5]. App use is also 
increasing. Only 15.3% of interns used an app daily in a 2012 study [1], compared 
with 50% in 2014 [5].  
 
Concern exists as to whether the apps available are trustworthy sources for clinical 
practice [3, 6]. Studies [7-15] from various disciplines have revealed poor levels of 
medical professional involvement (MPI), defined as whether a named clinician or a 
medically affiliated institution was involved in the development of the app.  
 
Regulatory bodies, such as the Food and Drug Administration (FDA) are becoming 
involved with the assessment of medical apps. They have divided medically 
related apps into three groups; those not considered a medical device, those that 
the FDA “intend to exercise enforcement discretion ‘over’ and those in which the 
FDA will become fully involved in regulating. Despite these regulations coming into 
play, concern still exists as to whether the three FDA groupings are “ambiguous 
and open to interpretation” [16].  
 
Other methods to improve credibility surrounding apps have been attempted. The 
Apple App Store™ have started removing certain drug reference apps which have 
not cited the source of their data [17]. No similar policy could be found for the other 
commonly used app stores. Websites have also been developed in an attempt to 
offer guidance as to the use of these apps. iMedicalApps.com is an example of 
such a site and is considered a trusted source by the Cochrane Collaboration [18]. 
However, these are not regulating bodies and they only offer advice on the 
available medical apps. 
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Independent studies [6, 8, 9, 19-28] have been performed to validate the use of 
specific apps such as medical calculators, screening tools and clinical tools. 
Difficulty in assessing these studies is due to the fact that many of them have 
evaluated selected apps from certain categories and different apps have been 
discussed in different studies. No comparison can be inferred. In some, the study 
did not include the names of the apps reviewed [29].  
 
These studies reveal that of the apps available, the possibility exists that the app 
has not been validated for use in a clinical setting. The aim of this study was to 
describe anaesthetists’ in the Department of Anaesthesiology at the University of 
the Witwatersrand (Wits) use of medically related mobile device apps and the 
assessment of the credibility of the most commonly used apps. 
 
Methods 
Approval to conduct the study was obtained from the Human Research Ethics 
Committee (Medical) (M150111) and other relevant authorities. The study 
population consisted of all 208 anaesthetists’ in the department. A sample size of 
approximately 60% of the department would be considered an adequate sample 
size. Convenience sampling was used. 
 
An anonymous, voluntary and self-administered questionnaire (see Multimedia 
Appendix 1) was compiled following a review of the literature and input from an 
information technology expert with a medical background. The questionnaire 
included the following information; demographic data (gender, professional 
designation, age group, years of experience and mobile device brand), data on 
medical apps used (the number of apps owned, frequency of use, factors 
influencing choice of app) and how the participant would rank their apps. A mobile 
device includes both smartphones and tablets. Tablets were included as they 
make use of the same apps that smartphones are capable of using.  
 
The questionnaire was distributed during weekly academic meetings. After 
completion, questionnaires were placed into a sealed collection box. Return of 
questionnaires implied consent. Questionnaires were analysed and the top five 
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most commonly used apps the in the department were identified and then 
assessed against a demographic and credibility template. 
 
At the time of release of this study, no formal assessment of an app could be 
found. A demographic and credibility template was developed after discussion with 
the same expert previously referred to. The template was divided into two 
sections: app demographics and credibility criteria and is shown in Table 1.  
 
Table 1 App demographic and credibility template  
Name of app 
Availability in app stores 
Cost 
Category (medical, health, lifestyle) 
Primary function (reference, calculator, etc.) 
Target population (doctors, patient, both) 
Is there MPI? 
 If yes, is medical professional named? 
 If no, does it cite source of information? 
User ratings in app stores  
 Number of reviews 
 Ratings 
Last update 
Independent reviews 
Independent validation 
 
iMedicalApps.com was used to determine if any independent reviews had been 
conducted on the five most commonly used apps. 
 
Data was entered and analysed on a Microsoft Excel spreadsheet. Descriptive 
statistics were used. Categorical variables were summarized using frequencies 
and percentages rounded to one decimal point. Missing data was recorded as "not 
specified." 
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Results 
A total of 127 questionnaires were distributed among anaesthetists at academic 
meetings between April and September 2015, with the return of 117 (92.1%). 
Therefore 56.3% participated in this study. Incomplete questionnaires were 
included in the sample. In one returned questionnaire, no demographic information 
was given but did however include two apps owned and therefore the 
questionnaire was included for the study. Three participants did not include their 
years of experience. This missing data was excluded from the specific analysis. 
 
The demographics of participants are shown in Table 2. 
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Table 2 Participant demographics 
Demographic Number (%)  
Gender     
Male 48 (41.0) 
Female 68 (58.1) 
Not specified 1 (0.9)  
Age group     
< 40 years 100 (85.5) 
 ≥ 40 years 16 (13.7) 
Not specified 1 (0.9)  
Designation 
Medical officer 18 (15.4) 
Registrar 53 (45.3) 
Consultant 45 (38.5) 
Not specified 1 (0.9)  
Years of experience 
≤ 5 years 71 (60.7) 
6 – 10 years 27 (23.1) 
1 – 15 years 4 (3.4) 
16 – 20 years 5 (4.3) 
> 20 years 6 (5.1)  
Not specified 4 (3.4) 
 
The brand of smartphones and tablets owned by participants is shown in Table 3. 
All 117 (100%) participants owned a smartphone and 100 (85.5%) participants 
owned a tablet as well. 
 
58 
 
Table 3 Smartphone and tablet brands ownership 
Brand of smartphone Number (%) 
Apple 71 (60.7) 
Samsung 36 (30.8) 
Sony 3 (2.6) 
Blackberry 2 (1.7) 
Nokia 2 (1.7) 
LG 1 (1) 
Other / not specified 2 (1.7) 
Tablet brand Number (%) 
Apple 77 (77.0) 
Samsung 16 (16.0) 
Asus 1 (1.0) 
Microsoft 1 (1.0) 
Other/not specified 5 (5.0) 
 
 
Of the 117 participants, 99 (84.6%) used a medically related app. App use 
according to participants demographics is shown in Table 4.  
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Table 4 Use of apps according to demographics 
Demographic Number (%) 
Gender (number)  
Male (49) 41 (83.7) 
Female (68) 57 (83.8) 
Age group (number)  
< 40 Years (100) 88 (88.0) 
≥ 40 years (17) 10 (58.8) 
Designation (number)  
Medical officer (18) 15 (83.3) 
Registrar (53) 46 (86.8) 
Consultant (46) 37 (80.4) 
Years of experience (number)  
≤ 5 years (71) 61 (85.9) 
6 – 10 years (27) 24 (88.8) 
11 – 15 years (4) 3 (75.0) 
16 – 20 years (5) 3 (60.0)  
> 20 years (7) 4 (57.1) 
 
 
The frequency of app use: daily use, use of at least a few times per week, less 
than weekly and never using the apps they own according to demographics is 
shown in Table 5.  
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Table 5 Frequency of app use 
Demographic Daily 
< Daily, 
<Weekly 
<Weekly Never 
No. No. (%) No. (%) No. (%) No. (%) 
Total (99) 29 (29.3) 39 (39.4) 29 (29.3) 2 (2.0) 
Gender 
    
Male (41) 9 (21.9) 20 (48.8) 12 (29.3) 0 (0) 
Female (57) 20 (35.1) 19 (33.3) 17 (29.8) 1 (1.8) 
Age group 
    
< 40 years 
(88) 
28 (31.8) 34 (38.6) 25 (28.4) 1 (1.1) 
≥ 40 years 
(10) 
1 (10.0) 5 (50.0) 4 (40.0) 0 (0) 
Designation 
    
Medical officer 
(15) 
6 (40.0) 5 (33.3) 4 (26.7) 0 (0) 
Registrar (46) 14 (30.4) 20 (43.5) 11 (23.9) 1 (2.2) 
Consultant 
(37) 
9 (24.3) 14 (37.8) 14 (37.8) 0 (0) 
Years of experience 
≤ 5 years (61) 19 (31.1) 25 (41.0) 16 (26.2) 1 (1.6) 
6 – 10 (24) 6 (25.0) 9 (37.5) 9 (37.5) 0 (0) 
11 – 15 (3) 1 (33.3) 0 (0) 2 (66.7) 0 (0) 
16 – 20 (3) 0 (0) 1 (33.3) 2 (66.7) 0 (0) 
> 20 (4) 1 (25.0) 3 (75.0) 0 (0) 0 (0) 
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A total of 76 different apps were listed by participants. The 5 most commonly used 
apps were Medscape, ECG Guide, Qx Calculate, The Oxford Handbook of 
Anaesthesia and Pedistat and are shown, by participant demographics, in Table 6.  
 
Table 6 Commonly used apps 
Demographic Medscape ECG Guide 
Qx 
Calculate 
Oxford 
Handbook 
Pedistat 
No. No. (%) No. (%) No. (%) No. (%) No. (%) 
Total (99) 61 (61.6) 10 (10.1) 10 (10.1) 9 (9.1) 9 (9.1) 
Gender 
     
Male (41) 25 (61.0) 4 (9.8) 5 (12.2) 5 (12.2) 6 (14.6) 
Female (57) 36 (63.2) 6 (10.5) 5 (8.8) 4 (7.0) 3 (5.3) 
Age group 
     
< 40 years (88) 55 (62.5) 10 (11.4) 10 (11.4) 9 (10.2) 9 (10.2) 
≥ 40 years (10) 6 (60.0) 0 (0) 0 (0) 0 (0) 0 (0) 
Designation 
     
Medical officer (15) 13 (86.7) 1 (6.7) 2 (13.3) 2 (13.3) 4 (26.7) 
Registrar (46) 23 (50.0) 2 (4.3) 5 (10.8) 4 (8.7) 4 (8.7) 
Consultant (37) 25 (67.6) 6 (16.2) 3 (8.1) 3 (8.1) 1 (2.7) 
Years of experience 
     
≤ 5 years (61) 38 (62.3) 5 (8.2) 7 (11.5) 7 (11.5) 8 (13.1) 
6 – 10 (24) 15 (62.5) 4 (16.7) 2 (8.3) 2 (8.3) 1 (4.7) 
11 – 15 (3) 3 (100) 0 (0) 1 (33.3) 0 (0) 0 (0) 
16 – 20 (3) 1 (33.3) 0 (0) 0 (0) 0 (0) 0 (0) 
> 20 (4) 2 (50.0) 0 (0) 0 (0) 0 (0) 0 (0) 
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Of the 99 participants who used apps in their practice, only 9 made mention of 
which factors had influenced their choice in downloading particular apps. These 
participants listed factors for 21 different apps. One app was chosen by a 
participant for two reasons and therefore 22 influencing factors are given as shown 
in Table 7. 
 
Table 7 Factors influencing choice of apps 
Factor No. (%) 
Recommended by colleagues 9 (40.9) 
Cost reasons 4 (18.2) 
Own search conducted on relevant store 7 (31.8) 
Saw others using it 1 (4.5) 
Ease of use 1 (4.5) 
 
 
Data of the five most commonly used apps were included in the demographic and 
credibility template, the details of which are given in Table 8. 
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Table 8 App demographic and credibility data of the most commonly used apps  
 
Medscape ECG Guide Qx Calculate 
Oxford 
Handbook 
Pedistat 
Availability 
     
iStore Yes Yes Yes Yes Yes 
Google Play Yes Yes Yes Yes Yes 
Cost 
     
iStore Free 
a 
R13.99 
a 
Free 
a 
R879.99 
a 
R39.99 
a 
Google Play Free 
a 
R46,26 
a 
Free 
a 
R751.62 
a 
R77.91 
a 
App category 
in store 
Medical Medical Medical Medical Medical 
Primary 
function 
Reference, 
Calculator 
Reference Calculator Reference Reference 
Target 
population 
Medical 
professionals 
Medical 
professionals 
Medical 
professionals 
Medical 
professionals 
Medical 
professionals 
MPI Yes Yes Yes Yes Yes 
If yes, is MPI 
named 
No 
b 
Yes Yes Yes Yes 
If no, is 
source cited? 
Yes - - Yes - 
User rating      
iStore  
 
All versions 
74 
    
Number of 
reviews 
Not enough 
ratings to give 
an average 
All versions: 
23 
Not enough 
ratings to give 
an average 
Not enough 
ratings to give 
an average 
     
Rating All versions: 
4.5/5 - 
All versions: 
4.5/5 
  
Google Play      
Number of 
reviews 
42024 123 7285 Not rated 110 
Rating 4.4/5 4.3/5 4.6/5  4.5/5 
Last update 23-May-16 3 Dec 2013 16-April-16 07-April-16 25-Feb-15 
Independent 
reviews 
Yes Yes Yes Yes Yes 
Independent 
validation 
ACCME 
accreditation 
No No No No 
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a Price at the time of submission of the research report. 
b Only Medscape did not specifically state the main contributors in the 
development, due to multiple contributors for the various topics. It is also 
continually being peer reviewed. The remaining four apps named the medical 
professionals involved in the development of the app. 
 
Discussion 
It was difficult to make comparisons with most other studies as they included 
mainly medical students or interns [1, 4, 5] and not anaesthetists. The study by 
Franko [2] included app use by different disciplines but again no specific mention 
of use in anaesthetists. No studies were found that reported findings according to 
participant’s demographics. In our study 88% of participants using apps were 
younger than 40 years. This is also reflected by the years of anaesthetic 
experience whereby those with less years of experience use apps more frequently. 
This may be explained that they are younger and more exposed to technology but 
also may need to access information more frequently. 
 
Previous studies with junior doctors showed an increase in smartphone ownership 
from 2012 through to 2014 [1, 3-5]. Nason et al [30] in 2014 showed that all 
urology registrars in their hospital owned a smartphone. Our study is consistent 
with that of Nason et al [30] as all participants did own a mobile device. Tablets 
were included as the larger screen may make them more user friendly and 
encourage app use. Our study found that Apple was the most popular brand of 
both smartphone and tablet and this is in keeping with previous studies [1, 2, 4, 5].  
 
The use of apps has also increased, as shown amongst junior doctors [3, 4]. This 
could be due to the increasing ownership of a mobile device and the availability of 
medically related apps. Comparing the use amongst anaesthetists however could 
not be done as no prior studies in this population group could be identified. 
Nason’s [30] study with urology registrars in 2014 showed that 77% owned at least 
one medical app. In our study 85% of anaesthetists owned at least one medically 
related app. The increase in app use between Nason’s [30] and our study may be 
due to our study being conducted more recently and the fact that app use has 
been rapidly increasing. The increase in app use can also be attributed to the fact 
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that a cellphone or tablet is more convenient to carry compared to textbooks or 
notes 
 
Daily use of apps increased from the study by Payne [1] in 2012, (29.6%) 
compared with those of O’Reilly [4], (43.6%), in 2013 and O’Connor [5], (50%), 
also in 2013 while the use of an app a few times per week decreased between 
these two studies [4, 5]. The majority of participants, (39.4%), in our study used 
their apps less than daily but more than weekly while daily use was only 29.3%. 
Daily use in previous studies [1, 4, 5] was higher than in our study, however they 
used interns and junior doctors whereas in our study more experienced doctors; 
medical officers, registrars and consultants, were used. 
 
Apps can be used by the medical fraternity for a variety of functions, which can be 
broadly defined into five categories; administration, health record and 
maintenance, communication, reference and information gathering, and lastly 
medical education and patient management [31]. Only the last two categories were 
considered in our study. These two categories were chosen as medical information 
obtained from these apps may have clinical implications for patients. Apps for 
communication, such as What’s App, may achieve a similar goal, however the 
source of information is a colleague and not information from the app itself.  
 
The commonly used apps appear to differ between different institutions [4, 5]. 
These could possibly reflect differences in those recommended by colleagues, 
preferences by particular institutions, cost or other factors discussed later. The 
study on urology registrars by Nason [30] showed the most popular app was a 
logbook, followed by the Oxford Handbook on Urology. O’Connor et al [5] showed 
that the British National Formulary was the most popular app in their study. The 
five most commonly used apps in our study were Medscape (61.6%), ECG Guide 
(10.1%), Qx Calculate (10.1%), the Oxford Handbook of Anaesthesiology (9.1%) 
and Pedistat (9.1%). Medscape was the most popular app used among all the 
demographic categories used. The remaining four apps commonly used were only 
used those participants with less than 15 years of experience. Medscape is a 
reference source, drug dosing reference and medical calculator and these multiple 
functions may possibly be the reason for its popularity.  
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Participants in our study were asked to give reasons for choosing their particular 
apps. The reasons given included recommended by a colleague (40.9%), cost 
(18.2%), their own search conducted (31.8%), saw others using it (4.5%) and ease 
of use (4.5%). Cost appeared to play a larger role in in the study by Nason [30] 
where only 30.6% of urology trainees reported paying for an app. However, 
O’Reilly [4] in 2013 found that the most commonly downloaded app by interns was 
the Oxford Handbook of Clinical Medicine, an app that cost €44.99 at the time. Our 
study also showed that cost was less important a factor as most of the commonly 
used apps were paid for. 
 
Despite app regulations coming into play, individual apps still appear to have 
shortcomings. One study [25] showed an overall accuracy of 98.6% amongst 
calculator apps used, with two of 14 apps having errors. The errors were related to 
the Child-Pugh and Model for End-Stage Liver Disease scores. Another study on 
calculator apps looked at fluid calculations for burns resuscitation, where two apps 
were compared to a simple calculator and all using the Parkland formula. There 
was no significant difference found between the time taken to calculation or 
accuracy [19]. Apps may also function as screening tools, such as that those for 
pain [32], depression [23], skin lesions [6], cognitive dysfunction [28].  
 
Drug dosing apps have also been reviewed. One such study involved using the 
British National Formulary for Children and comparing it to an ICU dose calculator 
with respect to adrenaline and dopamine infusions in clinical scenarios. All the 
participants, from student to consultant, were able to calculate correct adrenaline 
and dopamine doses using the app as opposed to only 28.6% using the British 
National Formulary for Children. [33]  
 
Other apps developed utilise features built into the mobile device, such as the light 
emitting diode flashlight, which has been used to measure heart rate [20, 21, 27, 
29], although most showed poor accuracy. The accelerometer, which is able to 
measure the tilt and positioning of the mobile device has been used to measure 
the degree of scoliosis [26] or range of motion of joints [22]. The screen of the 
mobile device may be used for any number of visually related functions, and has 
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been reviewed as a monitor for devices such as a pulse oximeter [34] or 
glucometer [24]. These are features not marketed for medical use by the mobile 
device manufacturers but which app manufacturers have utilised in the design of 
their apps. 
 
In the credibility assessment in our study, a template was developed to give an 
overview as to whether the information in the five most commonly used apps is 
reasonable for clinical use. Criteria based on limitations from previous studies 
were considered.  
 
All five of the most commonly used apps were found under the medical category in 
the app stores, and designed for use by medical professionals. In addition, they all 
had at least one named medical professional involved in their development. These 
apps were also independently reviewed by iMedicalapps.com. With regard to user 
ratings, ECG Guide, the Oxford Handbook and Pedistat did not have enough 
reviews to give an average rating on the South African iStore, although Google 
Play had averages for all the commonly used apps except for the Oxford 
Handbook. Where a rating was available, the lowest was 4.3/5 for ECG Guide. 
ECG Guide in addition has not been updated recently, the last update being 
December of 2013. Only ECG Guide and Pedistat did not have a recent update 
within the last few months. In addition to its high rating, Medscape is used as a 
platform for continuing education points, and thus is a requirement for up to date 
information. However, none of the apps had any independent studies conducted to 
test their content. These apps therefore do have a reasonable degree of safety for 
use in clinical practice. 
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1. Introduction  
 
The use of mobile devices, that is smartphones and tablet computers (tablets) as well as 
their related software applications (apps) has been increasing in the last few years. With 
this, medically related programs that can be used by both clinicians and patients alike 
have been developed. Within the medical field, mobile device use is popular and appears 
to be increasing, for example in the United Kingdom, between 74 to 87% of junior doctors 
owned a smartphone in 2011 and 2012 (1, 4, 5) to almost 100% reported in 2013 (2) and 
2014 (3). Among different specialties in a 2012 study in the United States of America, 
ownership ranged from 77.3% in radiologists to 98.1% in surgeons (5), whilst a study in 
Ireland reported 100% of urology trainees owning some form of smartphone (6).  
 
App use is also increasing. Only 15.3% of interns used an app daily in a 2012 study (1), 
compared with 50% in 2014 (3). The apps used depend on the speciality and possibly the 
institute. In two studies conducted in Ireland amongst junior doctors, one showed that 
the most commonly used app was the Oxford Handbook of Clinical Medicine (2), whilst 
the other showed the British National Formulary being the more popular (3). Specialists 
tend to utilise apps that are more relevant to their respective specialty (6). Another factor 
that may influence the apps used would be the cost. In these studies, approximately half 
of smartphone owners had apps that were paid for. (2, 6) 
 
Apps can be used by the medical fraternity for a variety of functions, which can be 
broadly defined into five categories; administration, health record and maintenance, 
communication, reference and information gathering, and lastly medical education and 
patient management (7).  
 
Concern exists as to whether the apps available are trustworthy sources for clinical 
practice (4). Studies from various disciplines have revealed poor levels of medical 
professional involvement (MPI), whether a named clinician or a medically affiliated 
institution. In a review of apps related to breast health, MPI was as low as 12.8% (11). 
Most reviews of health app groups, revealed MPI of between 21-37% (8, 9, 12, 14-16), 
although reviews looking at viral hepatitis and neurosurgery showed MPI of 56.5% and 
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66% respectively (10, 13). In a review of apps used for the conversion of opioids, the 
developer of one of the apps was found to be a “training grade doctor” (14) . 
 
Regulatory bodies, such as the Food and Drug Administration (FDA) are becoming 
involved with the assessment of medical apps. They have divided medically related apps 
into three groups; those not considered a medical device, those that the FDA “intend to 
exercise enforcement discretion” over and those in which the FDA will become fully 
involved in regulating. The latter two are referred to as a “medical device” (17). The 
European Commission and the South African Medicines Control have not specifically 
included apps in their guidelines and so they fall under the current heading of “software” 
(18, 19). 
 
Other methods to improve credibility surrounding apps have been attempted. The Apple 
App Store™ have started removing certain drug reference apps which have not cited the 
source of their data (24). No similar policy could be found for the other commonly used 
app stores. Websites have also been developed in an attempt to offer guidance as to the 
use of these apps. iMedicalApps.com is an example of such a site and is considered a 
trusted source by the Cochrane Collaboration (21). However, these are not regulating 
bodies and they only offer advice on the available medical apps. 
 
Despite these regulations coming into play, concern still exists as to whether the three 
FDA groupings are “ambiguous and open to interpretation” (20). Independent studies 
have been performed to validate the use of specific apps such as medical calculators, 
programs that can perform common clinical calculations (such as glomerular filtration 
rate) or calculate a value in a scoring system. One study (25) showed an overall accuracy 
of 98.6% amongst calculator apps used, with only two of the 14 apps having errors. The 
errors were related to the Child-Pugh and Model for End-Stage Liver Disease scores. 
Another study on calculator apps looked at fluid calculations for burns resuscitation, 
where two apps were compared to a simple calculator and all using the Parkland formula. 
There was no significant difference found between the time taken to calculation or 
accuracy (26). Apps may also function as screening tools, such as those for pain (31), 
depression (29), skin lesions (28), cognitive dysfunction (30). 
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Drug dosing apps have also been reviewed. One such study involved using the British 
National Formulary for Children and comparing it to an ICU dose calculator with respect 
to adrenaline and dopamine infusions in clinical scenarios. All the participants, from 
student to consultant, were able to calculate correct adrenaline and dopamine doses 
using the app and only 28.6% using the British National Formulary for Children. (27)  
 
Other apps developed utilise features built into the mobile device, such as the light 
emitting diode flashlight, which has been used to measure heart rate (32-35), although 
most showed poor accuracy. The accelerometer, which is able to measure the tilt and 
positioning of the mobile device has been used to measure the degree of scoliosis (36) or 
range of motion of joints (37). The screen of the mobile device may be used for any 
number of visually related functions, and has been reviewed as a monitor for devices such 
as a pulse oximeter (38) or glucometer (39). These are features not marketed for medical 
use by the mobile device manufacturers but which app manufacturers have utilised in the 
design of their apps.  
 
Difficulty in assessing these studies is due to the fact that they have evaluated individual 
apps and no similar studies were done with the same apps. No comparison can be 
inferred. In some, the study did not include the names of the apps reviewed (33).  
  
These studies reveal that of the apps available, the possibility exists that the app has not 
been validated for use in a clinical setting. The aim of this study was to describe 
anaesthetists’’ in the Department of Anaesthesiology at the University of the 
Witwatersrand (Wits) use of medically related mobile device applications and the 
assessment of the most commonly used apps credibility. 
 
2. Problem statement 
 
Mobile devices and their related apps are increasing in number and popularity with the 
medical community being no exception (1-6). Apps for a wide range of possible functions 
have already been developed for use in the medical field (7, 26-39). However, many of 
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these apps have no MPI, being a named healthcare worker, institution or manufacturer of 
medical equipment (8-16). Regulation of apps has recently been incorporated into 
guidelines (17) or are still in the process of having a set of guidelines drafted, where apps 
currently fall under the auspices of “software” (18, 19). However, regulation will only 
involve a certain subset of apps (17). 
 
In an attempt to improve safety surrounding the use of medical apps, certain websites 
have been developed by independent individuals that offer guidance but do not regulate 
apps (21). With the vast amount of possible functions, varying degree of MPI and low 
levels of regulation, safety remains a concern with the use of medical apps (20). Within 
the Department of Anaesthesiology at the University of the Witwatersrand (Wits), it is not 
known which apps are commonly used and what factors were involved in the decision to 
use those particular apps, whether financial constraints, recommendations from 
colleagues or other factors. 
 
3. Aim 
 
The aim of this study is to describe anaesthetists in the Department of Anaesthesiology at 
Wits use of medically related mobile device applications and the assessment of those 
apps most commonly used. 
 
4. Objectives 
 
The objectives of this study are to: 
 describe the use of apps by anaesthetists 
 describe what may influence anaesthetists choice of apps 
 assess the demographics and credibility of the five most commonly used apps in 
department.  
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5. Research assumptions 
 
The following definitions will be used in this study. 
 
Anaesthetist: in this study, is any qualified doctor working in the Department of 
Anaesthesiology, including medical officers, registrars and consultants. 
 
Medical officer: is a qualified doctor practising in the Department of Anaesthesiology 
under specialist supervision. Medical officers with more than 10 years of experience are 
regarded as career medical officers. 
 
Registrar: is a qualified doctor that is registered with the Health Professions Council of 
South Africa as a trainee specialist. 
 
Consultant: is a qualified doctor who is registered as a specialist anaesthesiologist with 
the Health Professions Council of South Africa or career medical officers. 
 
Mobile device: a portable computing device such as a smartphone or tablet.  
 
Smartphone: a mobile device that has the functionality of a computer, having access to 
the internet and capable of running apps on its operating system in addition to being a 
mobile phone. 
 
Tablet computer: a wireless portable personal computer with a touchscreen interface. A 
tablet computer will be referred to as a tablet in this study. 
 
Medically related app: software application that can be executed/run on a mobile device 
that is used for a medical purpose; e.g. reference material, diagnosis, scoring, monitoring. 
  
Demographic and credibility assessment template: a template checklist designed by the 
researcher as a basic assessment of the apps. 
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6. Demarcation of study field 
 
The study will be conducted in the Department of Anaesthesiology, affiliated to the 
Faculty of Health Sciences at Wits. The staff complement of the department is 27 medical 
officers, 107 registrars and 74 consultants. The following hospitals are affiliated to the 
university. 
 Charlotte Maxeke Johannesburg Academic Hospital, a 1200 bed central hospital 
 Chris Hani Baragwanath Academic Hospital a 2888 bed central hospital 
 Helen Joseph Hospital, a 500 bed tertiary hospital 
 Rahima Moosa Mother and Child Hospital, a 388 bed regional hospital 
 Wits Donald Gordon Medical Centre, a 190 bed public-private hospital. 
 
7. Ethical considerations 
 
Approval to conduct the study will be obtained from the Human Research Ethics 
Committee (Medical) and the Postgraduate Committee at Wits. 
 
Anaesthetists will be invited to participate in the study at departmental academic 
meetings. Those who agree will receive an information letter (Appendix 1) and a self-
administered questionnaire (Appendix 2). Implied consent will be assumed on return of 
the questionnaire. 
 
Anonymity will be ensured as data will be collected without identifying information. A 
study number will be allocated to each questionnaire to assess response rate. 
Confidentiality will be ensured as only researcher and supervisors will have access to the 
raw data.  
 
At the end of the study, the demographic and credibility assessment template will be 
made available to all anaesthetists in the department.  
 
Data will be stored securely for six years after completion of the study. 
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This study will be conducted according to the principles of the Declaration of Helsinki (41) 
and the Guidelines for Good Practice in the Conduct of Clinical Trials with Human Participants 
(42). 
 
8. Research methodology 
 
8.1. Research design 
A prospective, descriptive, contextual, research design will be followed in this study. 
  
A prospective study is one where data about a presumed case are first collected, and then 
the effect or outcome is measured (43). Data will be collected in the form of a 
questionnaire and the results evaluated thereafter. 
 
Descriptive designs are concerned with gathering information from a representative 
sample of the population (43). This study will collect data regarding mobile device app use 
from anaesthetists in the Department of Anaesthesiology. 
 
A contextual is defined as a study with a focus on particular contexts or a “small scale 
world”. It takes a small group or specific area and contextualises it to the overall 
population. (44). This study will be incorporating a small group of anaesthetists in one 
academic institution. 
  
8.2. Study population 
The study population consists of all the anaesthetists in the Department of 
Anaesthesiology at Wits. 
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8.3. Study sample 
Sample method 
Convenience sampling will be used in this study. This involves the choice of readily 
available subjects or objects for the study (43). Data will be collected during academic 
meetings when the majority of the department is available. 
 
Sample size 
The questionnaire will be administered to the entire accessible population. The sample 
size will be realised by the response rate. Approximately 124 (60%) of the departments 
members are available at any one time due to theatre commitments, outreach rotations 
and leave. 
 
Inclusion criteria 
The inclusion criteria for this study are:  
 anaesthetists (medical officers, registrars and consultants) employed by the 
department 
 who are willing to participate. 
 
8.4. Data collection 
Development of questionnaire 
Following a review of the literature a draft questionnaire was developed by the 
researcher with guidance from the supervisors. The draft questionnaire was reviewed by 
an information technology expert with a medical and the suggestions were incorporated. 
This ensured content and face validity of the questionnaire.  
 
The questionnaire (Appendix 2) will include the following information: 
 demographic data (gender, professional designation, age group, years of 
experience and mobile device ownership and brand) 
 medically related apps (the number of apps, frequency of use, factors influencing 
choice of app) 
 the ranking of the apps. 
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Development of demographic and credibility assessment template 
A review of the literature did not reveal a template for the assessment of the 
demographics and credibility of medically related apps. 
 
As such, a draft template was developed by the researcher and reviewed by an 
information technology expert with a medical background and the suggestions 
incorporated into the template. This template is to describe factors that could influence 
the credibility of an app and will be used by the researcher to assess whether an app has 
been developed by a credible source. 
 
The template (Appendix 3) will include the following information: 
 app demographics (available in both iTunes and Google Play, price, app category, 
app function) 
 credibility assessment (MPI, MPI named, source of information cited, user ratings, 
last update, independent reviews, independent validation) 
 
Data collection process 
Before departmental academic meetings, the convenor of the meeting will be approached 
and asked if the researcher can address the meeting. The researcher will explain the 
topic, after which anaesthetists will be invited to join in the study. It will be mentioned 
that even if potential participants do not own a smartphone or tablet, they are still 
eligible to participate. Individuals will be informed that participation is voluntary and 
anonymous. Those agreeing to participate will be given an information letter and a 
questionnaire. Questionnaires will be handed out and collected by the researcher. The 
researcher will be available to answer any questions. After completion, questionnaires 
will be placed into a sealed collection box. 
 
Questionnaires will be analysed and the five most commonly used apps the in the 
department will be ascertained. The researcher will then assess these apps using the 
demographic and credibility assessment template. 
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A search for reviews of alternate sites for credibility (iMedicalApps.com) will then be 
conducted to ascertain if medical peer review of the specific app has occurred. 
 
8.5. Data analysis 
Data was entered and analysed on a Microsoft Excel spreadsheet. Descriptive statistics 
were used. Categorical variables were summarized using frequencies and percentages 
rounded to one decimal point. Missing data was recorded as "not specified." 
 
9. Significance of the study 
 
Mobile device apps are in common use within the medical fraternity and use is increasing. 
They can be used for a multitude of purposes in the workplace which includes 
administration, communication, health records, referencing and education (7). Regulating 
bodies will not incorporate all medically related apps (17-19), despite many of these apps 
with a medical theme not having any form of MPI (8-16). Most studies evaluating apps 
have either taken a group of related apps and reviewed them or have taken a specific app 
to validate it for use (25-39). The results from this study will give an understanding of 
medically related app use in the department and whether the more commonly used apps 
are credible. 
 
10.  Validity and reliability of the study 
 
Validity is defined as “that which indicates whether the conclusions of the study are 
justified based on the design and interpretation” and reliability “is an indication of the 
extent of random error in the measurement method” (45)  
 
Reliability and validity in this study will be ensured by: 
 the appropriate study design 
 questionnaire developed following the literature review 
 experts reviewed the questionnaire ensuring face validity 
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 a standardised demographic and credibility assessment template was used to 
assess the credibility of the apps 
 checking 10% of data entries to confirm accuracy. 
 
11.  Potential limitations of the study 
 
This study is contextual in nature and reflects the smartphone and tablet ownership, in 
addition to their respective use of apps, within the Department of Anaesthesiology at 
Wits. It does not necessarily reflect that occurring within or Departments of 
Anaesthesiology or amongst anaesthetists in general.  
 
The possibility exists with convenience sampling that individuals who do not have a 
mobile device or use apps may not complete the questionnaire, giving a falsely high 
ownership of mobile devices in the department.  
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12.  Project outline 
 
A Gantt chart outlining the timeline of the project 
Activity Nov Dec 
Jan 
2015 
Sep Oct Nov Dec 
Mar 
2016 
April 
Proposal 
Preparation 
X         
Proposal 
Submission 
X         
Ethics 
Approval 
 X        
Postgrad. 
Approval 
  X       
Data 
Collection 
   X X X    
Data 
Analysis 
     X X   
Research 
report 
       X X 
Submission 
of work 
        X 
 
13.  Financial plan 
 
The Department of Anaesthesiology will incur the cost of printing and paper for the 
proposal, ethics and post graduate approvals. 
 
Item Cost Number Total 
Paper R1.00 per page 1200 pages R1200.00 
Binding R150.00 per book 3 books R450.00 
TOTAL  R1650.00 
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Appendices 
 
Appendix 1: Participants information letter 
Dear colleague, 
Hi, my name is Garth Bartlett and I am a registrar in the Department of Anaesthesiology at Wits. 
 
I would like to invite you to participate in my MMed research topic entitled: Anaesthetists Use of 
Medically Related Mobile Device Applications and the Evaluation of Those Most Commonly Used. 
The aim of this study is two-fold. The first part aims is to determine the commonly used 
smartphone and tablet applications (apps) within the Department of Anaesthesiology at Wits. 
Apps are becoming widely used as a reference source and tool in the medical field, yet many do 
not mention the source of the information that they contain. The second part is to determine if 
those apps commonly used by the department are credible for use in a medical setting.  
 
The study is approved by the Human Research Ethics Committee (Medical) (M150111) 
 
Participation in this this study is voluntary and consent to participate will be implied on return of a 
completed questionnaire. Information will be anonymous as no personal information will be 
required, questionnaires will be numbered for practical reasons. No numbers will be used to 
identify participants. Confidentiality will be ensured as only my supervisors and I will have access 
to the raw data. There will be no penalty for not participating or withdrawing from the study. If 
you do not own a smartphone or tablet but still wish to participate in the study, please complete 
the questionnaire up to question 5. If you own a smartphone and/or a tablet but do not use 
medically related apps and you wish to participate, please answer up to question 8. 
 
The questionnaire should not take more than 10 minutes to complete. Before completion of the 
questionnaire, please ensure you understand the above information. All returned questionnaires 
should be placed into the sealed box provided.  
 
Your time is greatly appreciated. Any questions regarding this study may be directed to me on 
083-469-4699 or the Chairman, Human Research Ethics Committee (Medical) on (011) 717-1234 
 
Sincerely,       Garth Bartlett 
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Appendix 2: Questionnaire 
Study Number: 
Mobile device app use in the Department of Anaesthesiology 
1) What is your gender? M F 
   
2) What is your designation? (MO, registrar, consultant)  
   
3) Age group < 40 years ≥ 40 years 
   
4) Years of experience  
   
5) Do you own a smartphone or tablet? Y N 
   
6) If you own a smartphone, what brand is it? (Apple, 
Blackberry, Samsung, other) 
 
   
7) If you own a tablet, what brand is it? (Apple, Samsung 
other) 
 
   
8) Do you use medically related apps in your practice / 
study? 
Y N 
   
9) How many medically related smartphone applications 
do you own? 
 
  
10) How often do you use one or more of your medically 
related apps? 
At least once daily 
Few times per week 
Less than weekly 
Never 
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11) Please rank your top five most commonly used medical 
apps, from most common to least and what factor 
made you decide on that particular app 
 
If you own less apps, please rank those you do from 
most to least 
 
1) ___________________ 
 
 
 
2) ___________________ 
 
 
 
3) ___________________ 
 
 
 
4) ___________________ 
 
 
 
5) ___________________ 
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Appendix 3: Demographic and credibility assessment template of the five 
most commonly used apps 
Name of app  
Availability 
iTunes Google Play 
  
  
Cost  
  
Category (medical, health, lifestyle)  
  
Primary Function (reference, calculator etc.)  
  
Target population (patient, doctor, both)  
  
Is there documented MPI?  
   
 If MPI, is MPI named  
   
 
If no MPI, does it cite source of 
information? 
 
  
User Ratings  
  
Last update  
  
Independent reviews  
  
Independent validation 
 
 
 
 
